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GENERAL INTRODUCTION 
 
Drosophila melanogaster has from nearly a century a fundamental 
role in the understanding of the basis of genetic mechanisms, due to the 
relative semplicity of its genome, to the short life cycle, to the abundance of 
the progeny and to the great amount of genetic markers of its body wall. 
From the pioneering studies of Thomas Hunt Morgan and the 
members of his laboratory, the fruitfly has early become the best 
characterized model organism for genetic studies. Moreover, the 
development of mutagenesis techniques by nobel prizes Christianne 
Nüsslein-Volhard and Eric Wieschaus has permitted the isolation and 
characterization of a large number of genes involved in each step of 
Drosophila development. With the advancement of molecular biology 
techniques and genome sequentiation, this animal represents today an 
excellent model to understand the genetic mechanisms at the basis of 
almost all metazoan development. 
The fruitfly is a holometabolous organism, characterized by a life 
cycle that starts from an embryonic stage, made inside the egg, followed by 
three larval instars (L1, L2, L3), during which the larva increases its 
dimensions. At the end of the third larval instar, at the pupal stage, a 
catastrophic metamorphosis occurs characterized by the histolysis of the 
larval tissues and by imaginal tissues differentiation, responsible for the 
adult appendages definition. 
At the end of this stage the adult insect (also called imago) ecloses. 
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The life cycle of a wild type organism is about ten days at 25°C. 
 
 
LARVAL AND PUPAL DEVELOPMENT (M. Ashburner, K. G. Golic, R. 
Scott Hawley, Drosophila a laboratory Handbook) 
 
After 23h AEL, L1 larva emerges; the three larval instars are spaced 
out by moults and followed by metamorphosis. Moults and metamorphosis 
are governed by ecdysone peaks, a steroid hormone produced by the ring 
gland. Larval body is composed of two cellular types: larval cells, that are 
polyploid, and imaginal cells, that are diploid. 
Imaginal cells segregate precociously from the surrounding larval 
cells, forming small cell groups at 9-10h AEL and are organized in two 
fundamental groups, imaginal discs and abdominal histoblasts. 
Imaginal discs begin an intense proliferative activity from the second 
larval instar until pupariation, while abdominal histoblasts proliferate later, 
during the pupal stage. At this moment the majority of larval cells are 
eliminated and substituted by imaginal cells that originate the integument 
and the adult appendages. 
Imaginal discs originate the structures of the head, thorax external 
appendages, genitalia and adult muscles. The histoblats originate the 
abdomen structures with the exception of the 8th segment that derivates 
from the genital imaginal disc. 
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Each imaginal disc at the end of larval development is constituted by 
a pseudostratified columnar epithelial tissue, that represents the actual 
imaginal disc, and by a squamous epithelium that forms the peripodial 
membrane. The first one originates the integument and the appendages, the 
second one originates the epithelial veil that welds the structures derived 
from different imaginal discs. 
Imaginal discs location in the larval body is peculiar for each one of 
them (Fig.1). 
 
 
Figure 1 - Localization of the imaginal discs in the larva at the L3 instar (Bate e Martinez-
Arias, 1991). 
 
One interesting feature of imaginal discs is their ability to survive, 
metamorphose and differentiate after transplantion in adult flies’ abdomen, 
(Schubiger et al, 1969; Simcox et al., 1989). Fragments of imaginal discs 
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can regenerate the entire disc structure and experiments in this direction 
allowed the characterization of “fate maps” of regeneration (Bryant, 1978). 
The wing imaginal disc is an excellent model for the elucidation of 
organogenesis and proliferation mechanisms; at the end of L3 it is 
subdivided into a series of folds (Fig. 2). The centrifugal regions of the 
imaginal disc originate the thorax structures: notum and pleura. The middle 
region originates the hinge region while the central region is the 
presumptive territory from which the wing lamina differentiates. Imaginal 
tissues are virtually two-dimensional structures, but they originate adult 
appendages with three axes (AP, DV, PD); this is due to a mechanism of 
eversion during methamorposis, in which the most central regions of the 
disc originate the distal structures, while the external regions originate the 
most proximal structures of the appendage. 
 
 
Figure 2 - Schematic representation of the wing imaginal disc at L3 instar (A) and of the 
adult wing (B). Different colors in the figure A indicate the presumptive territories of the 
structures visualized in B [from Bate and Martinez-Arias, 1991]. 
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HOW MULTICELLULAR ORGANISMS GET THEIR SIZE: THE 
IMPORTANCE OF CELL GROWTH 
 
In addition to being the unit of life, the cell is also the unit of growth.  
Growth is an increase in mass over time, and the term can describe 
mass increase of individual cells (“cell growth”) as well as tissues, organs or 
entire animal growth (“growth”). Understanding what regulates the overall 
growth of a cell and how cell growth is coordinated with progression through 
the cell cycle are important problems in biology. 
Recently, converging studies of cell growth and proliferation, pattern 
formation, endocrine regulation and evolution have generated new 
perspectives to these problems. Progress in the insect model systems has 
been particularly noteworthy, as genetic studies in Drosophila melanogaster 
have converged with classical endocrinological studies in other insects to 
generate a hypothesis to explain body size, if not shape and form. The 
physiology of growth control in insects is, of course, different to that in 
mammals, but the genes and signalling pathways that are involved are 
surprisingly similar. 
Insects do not grow as adults, and so their final size can be 
considered, to a first approximation, as a product of their growth rate during 
the larval phases and the duration of this growth period. 
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REGULATION OF SIZE: VARIATION IN PLOIDY 
 
The first evidence that animals can monitor dimension came from 
haploids and polyploids. For a given cell type, cell size is usually 
proportional to ploidy. Hence haploid cells are about half the volume of 
diploid cells, diploid cells are about half the volume of tetraploid cells, and 
so on.  
The ploidy of newts and salamanders can be manipulated to produce 
animals with chromosome complements ranging from haploid to pentaploid 
(Humphrey et al., 1957). In all cases, animals with unusual ploidy grow to 
the normal (diploid) size but contain very different numbers of cells. Thus 
mature tetraploid salamanders (Amblystoma mexicanum) look little different 
from diploid ones despite having half the number of cells. 
Mammals are not so robust; tetraploid mice usually die in utero. 
However, they compensate for the larger size of their cells by a reduction in 
cell number (Henery et al., 1992). After birth, these mechanisms of 
compensation seem not to operate in mammals. Knockout mice that lack 
p27, an inhibitor of the cyclin D- and cyclin E-associated kinases which are 
required for entry into S phase, are born normally sized but subsequently 
grow considerably larger than littermates (Fero et al., 1996; Kiyokawa et al., 
1996; Nakayama et al., 1996). The increase is a result of increased cell 
proliferation. In these knockout mice, increased cell proliferation does not 
result in a compensatory decrease in cell size. 
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In Drosophila the growth and final size of diploid/haploid mosaics is 
about normal (Santamaria, 1983), the haploid regions of such flies 
containing more numerous but smaller cells. The ploidy of Drosophila cells 
can be increased by loss of function of the cyclin-dependent kinase Cdc2. 
Cdc2 is required for mitosis in Drosophila and when the Cdc2 gene is 
inactivated in cells of the wing imaginal disc, cells switch from a mitotic cycle 
to cycles of endoreduplication without division (Fig 3 A-B) (Weigmann et al., 
1997).  
  
Figure 3. Pattern can be conserved indipendently of cell numeber or size. Left: 
Inactivation of Cdc2 by the use of a temperature sensitive allele (Cdc2E1-24) specifically in 
the anterior compartment of the wing disc (upper part) does not change shape and size of 
the wing, even though the affected region contains fewer but much larger, polyploid cells. 
Cell size is visualized by DNA staining. Wild-type (A). Cdc2E1-24, en-Gal4; UAS-Cdc2+ (B) 
[from Weigmann et al., 1997]. 
Right: Wing imaginal discs in which the cell density of the posterior compartment has been 
manipulated. There is no change in the shape and size of the compartments or the wing. 
The interface between A and P cells was drawn with a dotted line. C is entirely wild type. In 
(D) the P compartment has many more cells; in (E) many fewer cells than normal. The A 
compartment in (D) and (E) has normal cell densities [from Neufeld et al., 1998]. 
 
The effects of polyploidy argue that there is a strong positive 
relashionship between genome size and cell size. However, different cell 
types within a multicellular organism often vary in size, despite containing 
identical genomes of the same ploidy. Thus, there is not a strict adherence 
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to a DNA:Cytoplasm ratio, indicating that amount of DNA is not the sole 
determinant of cell size. 
However these experiments seems to demonstrate that changes in 
cell number can be compensated for by changes in cell size, both locally in 
groups of cells, or more globally in the whole compartment. 
 
 
MEASURING DIMENSIONS: THE STANDING OF NUMBERS 
 
During the growth of most organs, rates of cell growth and cell 
division are coordinated so that cell size does not change much over time, 
in other words growth is normally accompanied by an increase in cell 
number. The mechanisms that match rates of cell growth with cell division 
are mysterious, and are only recently being addressed in metazoans.  
Whereas mitotic cells often coordinate growth with division, in many 
natural processes the two phenomena can be separated. Early 
embryogenesis, for example, involves several rounds of division without 
growth and endoreplication, by the other side, it consists in growth without 
cell division. 
In the developing Drosophila wing discs, growth can be uncoupled 
from cell division (Fig.3 C-E). For example, when cell division is slowed or 
blocked, cells continue to accumulate mass (cell growth) and hence 
increase in size. Conversely, when division rates are accelerated by 
overexpression of specific cell-cycle regulators, cell growth rates are 
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unaffected and cells divide at smaller size (Neufeld et al. 1998). These 
observations demonstrate that, in metazoans, cell division rates do not drive 
cell growth. It is still unclear whether the opposite is true and cell growth is 
sufficient to drive cell division.  
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EXTRINSIC AND INTRINSIC REGULATION OF SIZE 
 
The identity of a particular organ, the position of a cell within this 
organ and its interactions with neighboring cells all play important roles in 
determining cellular growth rates. Although different models have been put 
forward to explain this local, organ-intrinsic control of growth, its molecular 
basis has remained elusive. In addition to local control, cells also 
experience more global signals that control their growth rates. Temperature 
and nutrient availability, for example, strongly influence growth rates and 
can affect the final size of many animals. 
It seems that, generally, extrinsic mechanisms are concerned with a 
link between growth and nutrition; they are not involved in proportion and 
pattern, but do affect the rate of growth and also the final size of the fly. 
Edgar and colleagues (Johnston et al., 1999) have argued that nutrition-
based and pattern-based regulation of growth operate in distinct ways: 
nutrition regulates the cell cycle via myc-dependent cyclin E regulation, 
acting at the G1/S checkpoint, and pattern acts through cdc25/string which 
intervenes at the G2/M checkpoint. 
Our emphasis in this essay is on the nutrition-based regulation of 
growth and myc role in size determination. 
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NUTRIENTS AVAILABILITY INFLUENCES GROWTH RATES 
 
Body and organ size are related to nutrition: poorly fed Drosophila 
larvae develop more slowly and can produce smaller flies. The wings of 
such flies are smaller because they contain smaller and fewer cells. Apart 
from this reduction in size, wing pattern is unaffected (Robertson, 1972; 
Bryant and Simpson, 1984). 
Dietary protein restriction has been shown to extend Drosophila 
development from 5 days to several weeks under constant temperature 
conditions. Not surprisingly, larval growth can be arrested by removing 
dietary proteins completely. This treatment rapidly arrests cell growth and 
DNA replication in most of the differentiated larval-specific tissues, but if the 
minimum viable weight (weight at which larvae can develop into adults if 
food is completely withdrawn) has been attained, the progenitor cells that 
will form the adult continue to grow and proliferate (Britton et al., 1998), 
eventually generating a small but otherwise normal fly.  
The fact that cells can grow within a starved animal indicates that the 
haemolymph (blood fluid) in such animals is not critically depleted of 
nutrients. Indeed, D. melanogaster and other insects are known to maintain 
haemolymph nutrients when they are starved by mobilizing triglycerides and 
glycogen stored in the fat body, a mesoderm-derived energy-storage organ 
that fulfills the functions that are assumed by the liver and adipose tissues in 
mammals (Bradley and Leevers, 2003; Mirth and Riddiford, 2007) . 
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Nutrient mobilization from the fat body is mediated by the induction of 
metabolic neuropeptides called adipokinetic hormones (AKH), which are 
produced by the Corpora Cardiaca, a region of the neuroendocrine Ring 
Gland (Fig.4). AKHs function analogously to vertebrate glucagons and, 
together with insulin-like peptides (ILPs), are part of an endocrine signalling 
system that allows the animal to coordinate rates of cell growth and 
changes in diet, with minimal disruption of the developmental programme. 
 
Figure 4. Schematic representation of Drosophila stomatogastric Nervous System and 
Ring Gland. 
 
 
INSULIN/INSULIN-LIKE GROWTH FACTORS SIGNALING 
 
The insect Insulin/Insulin - like growth factors system (IIS) (Fig.5) is 
highly homologous to that found in mammals. IIS activity promotes glucose 
import and nutrient storage in the fat body and other organs, fulfilling the 
homeostatic function of vertebrate insulins (Shingleton et al., 2005). In this 
capacity, it affects feeding behaviour, lifespan and reproduction. During 
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development, IIS also regulates cell growth, fulfilling the developmental 
function of the mammalian insulin-like growth factors (IGFs) (Efstradiatis 
1998). 
IIS activity has been manipulated in various ways in D. melanogaster, 
using the Gal4–UAS system (Brand and Perrimon, 1993) to overexpress 
genes in specific tissues, and the Flp–FRT system (Xu and Rubin, 1993) to 
delete gene functions in specific tissues at defined times. 
These manipulations show that many IIS components not only are 
essential for cell and organ growth, but are also sufficient to autonomously 
increase the growth rate of about any cell type in D. melanogaster. In whole 
animals, increased expression of several of D. melanogaster’s seven 
Insulin-like peptides (ILPs), a class of peptide hormones homologous to 
vertebrate insulins and insulin-like growth factors, can increase both larval 
growth rates and adult size (Brogiolo et al., 2001; Ikeya et al., 2002), 
whereas ablation of the small cluster of medial neurosecretory cells (mNSC) 
in the brain, which are the principal source of ILPs, reduces growth rates 
and final body size (Ikeya et al., 2002). 
ILPs bind the insulin receptor and promote cellular glucose import, 
energy storage in the form of glycogen and triglycerides, and cell growth. 
Drosophila melanogaster has seven paralogous genes (dILPs 1-7) 
expressed in different clusters on mNSCs (Ikeya et al., 2002). 
Activation of the InR/PI3K by dILPs increases macromolecular 
synthesis and this is most likely responsible for the potent effects of 
InR/PI3K on cell size. The ability of different cell types to respond to insulin 
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(or other growth factors) could be regulated by their accessibility to the 
ligand(s), or by their expression of the receptors or downstream 
components. Different expression levels of these components could dictate 
cell-type-specific size control. 
 
Figure 5. Drosophila Insulin pathway. Upon binding its ligand (ILPs), dInr activates an 
evolutionarily conserved signal transduction cascade. PI3K is recruited to an activated 
insulin receptor (InR) through an insulin receptor substrate and an adaptor protein, p60. In 
turn, the membrane localization of PI3K allows it to phosphorylate phosphatidylinositol-4,5-
P2 (PtdIns[4,5]P2), producing phosphatidylinositol-3,4,5-P3 (PtdIns[3,4,5]P3). This second 
messenger then recruits and activates protein kinase B (PKB), in cooperation with 
phosphoinositidedependent kinase (PDK). A negative regulator of this pathway is the 
phosphatase PTEN, which converts PtdIns(3,4,5)P3 back into PtdIns(4,5)P2. Together with 
the pathway acting through dTOR and the ribosomal protein S6 kinase (dS6K), the dInr 
pathway controls the activity of the protein translation machinery. [modified from Edgar 
2006] 
 
 
 
TOR (Target of Rapamycin) AND THE NURIENTS SENSOR CASCADE 
 
Given a cue to grow, such as insulin signaling, a cell needs a 
nutrient-rich environment to execute the command. One proposed 
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mechanism for a cell to sense its environment involves the target of 
rapamycin, TOR. TOR was first identified in yeast as a mediator of protein 
synthesis in response to nutrients (reviewed in Schmelzle and Hall, 2000) 
and has been shown to regulate translation, ribosome biogenesis and 
uptake of amino acids. 
The first genetic analyses of TOR in a multicellular animal were 
performed by two laboratories using Drosophila (Oldham et al., 2000; Zhang 
et al., 2000). The researchers found that cells mutant for TOR were reduced 
in size at all stages of the cell cycle. In addition, TOR mutant animals had a 
growth arrest phenotype reminiscent of amino acid withdrawal (Zhang et al., 
2000). Genetic epistasis tests demonstrated that in TOR/Pten double 
mutants, the phenotype of the TOR mutation was dominant, implying that 
TOR is required for the increased growth resulting from elevated insulin 
signaling.  
Further observations support the argument that TOR does not 
function downstream of InR/PI3K in a simple, linear pathway. First of all, 
careful examination of cell-size defects in endoreplicating cells revealed that 
cells mutant for TOR were phenotypically different from cells mutant in the 
Insulin Receptor Substrate (IRS)/chico: loss of TOR demonstrated a more 
pronounced decrease in cytoplasmic volume relative to the nuclear 
compartment (Oldham et al., 2000). Second, in contrast to the cell-
enlargement phenotypes seen following increases in InR/PI3K activity, 
overexpression of TOR reduced cell size. This contraddictory effect of TOR 
on growth has been repeatedly documented (Hennig et al., 2002) but has 
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no obvious molecular explanation and will be addressed later on in this 
dissertation. 
TOR has been well documented as responsive to nutrients in yeast 
and tissue culture, but despite intensive study, it is still unclear how it 
senses environmental conditions and how this pathway relates to the 
InR/PI3K pathway in multicellular organisms.  
Recent work on the two effectors of TOR signaling, S6K and 4EBP 
has supported the role of TOR in maintenance of cell size. S6 kinase (S6K) 
is implicated in promoting translation of proteins involved in ribosomal 
assembly, and requires TOR (Oldham et al., 2000) and PDK (Radimerski et 
al., 2002) for activation. 4E-BP is a negative regulator of the translation 
initiation factor, eIF4E. 
A mutant version of 4E-BP, which binds to eIF4E more strongly than 
wildtype, was used to perturb eIF4E function in Drosophila (Miron et al., 
2001). Overexpressing the modified 4E-BP in transgenic animals resulted in 
a cell-size decrease. However, co-overexpression of eIF4E was not 
sufficient to bypass the effect of 4E-BP. The failure of TOR overexpression 
to promote cell size and the inability of eIF4E to counter 4E-BP inhibition 
suggests regulation beyond total levels of TOR and its effectors. 
Modification by phosphorylation could be this additional level of control. For 
example, coexpression of the kinase PDK greatly enhances S6K-directed 
growth (Radimerski et al., 2002) and mutation of phosphorylation sites of 
eIF4E impedes normal growth (Lachance et al., 2002) . 
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Proteins of the TSC complex (TSC1 and TSC2) have been identified 
as potential upstream negative regulators of TOR (McManus and Alessi, 
2002), and may also play a role in nutrient sensing. In cells lacking TSC1 or 
TSC2, phosphorylation of S6K is resistant to amino acid deprivation; 
conversely, increased levels of TSC1 and TSC2 prevent S6K 
phosphorylation even in the presence of abundant amino acids (Gao et al., 
2002). 
Recent studies in Drosophila have identified the small GTPase Rheb 
as a link between TSC1/TSC2 and TOR (Saucedo et al., 2003; Stocker et 
al., 2003). Rheb, which is inhibited by the GTPase activating protein (GAP) 
activity of TSC2 (Zhang et al., 2003), appears to be a proximal activator of 
TOR, although its mechanism of action remains to be elucidated. 
S. pombe mutants for rheb (rhb1) arrest in G0/G1 as small, rounded 
cells (Mach et al., 2000; Yang et al., 2001), suggesting a role for Rheb in 
cell cycle progression and cell growth. 
Highly conserved Rheb genes have been described throughout the 
metazoa (Yamagata et al., 1994; Reuther and Der, 2000; Urano et al., 2000; 
Urano et al., 2001; Im et al., 2002; Panepinto et al., 2002). Drosophila Rheb 
(dRheb) has both GTP binding and GTPase activities (Patel et al., 2003).  
Overexpression of dRheb results in tissue overgrowth and increased 
cell size in the whole organism, and transition into S phase and cell growth 
in culture. Conversely, reduction of dRheb activity results in reduced tissue 
growth and smaller cell size in the whole organism, as well as G1 arrest and 
smaller cell size in culture (Patel et al., 2003; Stocker et al., 2003). 
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dRheb overexpression is sufficient to counteract the effects of 
aminoacid deprivation, since, despite the lack of aminoacids, larval cells 
expressing dRheb reach normal size (Stocker et al., 2003). 
The results of treating S2 cells and flies with Rapamycin, an inhibitor 
of TOR, suggest that the effects of dRheb are probably mediated by dTOR. 
At this regard, our data (see Results) show for the first time a growth 
effect, enhanced by Rheb, which seems to be, at least in part, indipendent 
from TOR, opening the possibility for the existence of another level of size 
regulation in response to nutrients availability.  
Finally, TOR has recently been shown to form a nutrient-dependent 
complex with a WD40 and HEAT repeat-containing protein, raptor, which 
appears to have both positive and negative effects on TOR activity, perhaps 
depending on nutrient levels (Hara et al., 2002; Kim et al., 2002; Loewith et 
al., 2002). 
Although the dissection of the activity of TOR presents some 
complexities, TOR is clearly required for maintaining normal cell size and 
permitting growth-factor-mediated cell hypertrophy. 
 
 
CROSSTALKS BETWEEN InR AND TOR SIGNALING 
 
Apparently cells are instructed to grow according to two different 
extracellular inputs: growth factors on one hand, activating a PI3K-mediated 
signaling, and nutritional cues on the other triggering a TOR-mediated 
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signaling response. These two signaling pathways are known to send 
branches to each other. 
Inhibition of TOR with rapamycin can potently block activation of S6K 
in response to  growth factors, and thus TOR function is required for 
effective growth factor signaling (Jacinto and Hall, 2003). However, 
immunokinase assays have found that TOR activity increases only slightly 
in response to growth factors (Burnett et al., 1998). Furthermore, mutant 
forms of S6K have been isolated that are resistant to rapamycin and amino 
acid withdrawal, but remain sensitive to wortmannin, a PI3K inhibitor (Hara 
et al., 1998; Weng et al., 1995b). 
Thus TOR and PI3K appear to regulate essentially parallel signaling 
pathways which may ultimately converge on common targets. In this sense, 
TOR signaling can be thought of as a nutrient-dependent checkpoint on 
growth factor signaling. The modest increase in TOR activity that does 
occur in response to growth factors was initially thought to be mediated 
through phosphorylation of TOR by Akt, which can directly phosphorylate 
TOR in vitro on sites whose phosphorylation is serum sensitive in vivo 
(Scott et al., 1998). However, mutation of these sites to alanine does not 
diminuish signaling downstream of TOR (Sekulic et al., 2000); furthermore, 
these sites are not conserved in the fly, worm or plant TOR homologs. 
Recent experiments suggest that a link between PI3K and TOR may occur 
through Akt-mediated phosphorylation of TSC2, which was found to disrupt 
and inactivate the TSC1/TSC2 complex (Dan et al., 2002; Inoki et al., 2002; 
Potter et al., 2002). It will be important to determine whether 
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phosphorylation by Akt is a critical factor regulating TSC function during 
normal development. 
An additional level of cross-talk between the PI3K and TOR pathways 
occurs through a negative feedback loop involving TOR-mediated inhibition 
of IRS1/chico, an adapter protein required for PI3K activation by the insulin 
receptor. Activation of TOR results in phosphorylation and subsequent 
proteasomal degradation of IRS1, leading to reduced PI3K signaling (Haruta 
et al., 2000). Similarly, mutations in S6K have been found to increase the 
kinase activity of Akt in Drosophila (Radimerski et al., 2002). 
These trans-pathway interactions are likely to play an important role 
in coordinating cell growth with other metabolic programs. 
 
 
THE WELL DOCUMENTED ROLE OF myc IN GROWTH CONTROL 
 
Myc proteins are members of the basic-helix-loop-helix-zipper class 
of transcription factors and are deregulated in several human cancers 
(Nesbit et al. 1999). c-Myc expression is quickly induced in response to 
many mitogens but the promoter elements directing induction are not well 
characterized. 
Numerous reports have indicated that Myc family members activate 
transcription of genes involved in protein synthesis and cellular metabolism 
(Coller et al., 2000; Guo et al., 2000; Boon et al., 2001). These functions 
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correlate well with Myc’s ability to promote cell size increases in tissue 
culture and in vivo (Johnston et al., 1999) when overexpressed. 
A recent publication of an allelic series of c-myc-hypomorph/null mice 
demonstrated that Myc regulates body size in mice by controlling cell 
number without detectable changes in cell size (Trumpp et al., 2001). 
Animals with reduced levels of c-Myc weighed less than normal 
counterparts and the weight loss was distributed among all organs. The 
researchers performed flow cytometry on dissociated cells from several 
organs and found no decrease in cell sizes as measured by forward scatter. 
Additionally, no differences in cell size were seen in haematopoietic cells or 
primary embryo fibroblasts. However, cell number was lower in the spleen, 
lymph nodes, and bone marrow of mutant mice. 
This observation, along with the discovery that primary fibroblasts of 
embryos with decreased c-myc have an elongated cell cycle, led the 
authors to conclude that c-Myc is not required for cellular growth but rather 
that c-Myc controls the decision to divide or not divide. Another 
interpretation of these data is that cell growth and proliferation are coupled 
in these animals. In this case, a defect in cell growth would, by default, 
result in fewer cells. 
Two other groups used tissue-specific deletion of c-myc to examine 
its role in haematopoetic cells (de Alboran et al., 2001; Douglas et al., 2001). 
In these studies, absence of myc prevented activation of B- and T-cells, 
which involves a growth transition from small to large cells. This result 
differs from Trumpp et al., who reported normal T-cell activation in the 
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absence of myc, leaving the necessity of Myc for growth-coupled maturation 
of B and T-cells uncertain. 
There are three myc family members in mammals, and it remains to 
be examined whether L- or N-Myc has a role in maintaining cell size. 
Years of research on c-Myc in mammalian systems have led to a 
dauntingly diverse range of potential genetic and functional targets. Yet it 
has remained difficult to evaluate Myc’s function in its entirety due to 
redundancy among family members, tissue specificity, and complex 
phenotypes. 
These problems spurred the search for Myc in genetically tractable 
animal models, and led to the identification of Myc family members in 
zebrafish, in the nematode Caenorhabditis elegans, and in Drosophila. 
The relatively simple genome and the highly developed genetics that 
Drosophila offers have made it the model of choice for the study of Myc 
family members. In fact, the very first myc mutant of any was identified as a 
spontaneous mutation in Drosophila in the 1930s by Eleanor Nichols-Skoog 
and Calvin Bridges, which they called diminutive (dm), for its smaller body 
size. dm was identified as a mutation in the Drosophila myc (dmyc) gene in 
1996, and since then more than a dozen mutations of dmyc have been 
characterized (Gallant et al., 1996; Schreiber et al., 1990). 
In the last several years, work on dMyc has clarified some of the 
protein’s more enigmatic functions and also led to the identification of new 
functional roles. 
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The single myc gene of Drosophila can partially rescue the 
proliferation defect of fibroblasts from c-myc mutant mice, suggesting 
shared functional targets (Trumpp et al., 2001). 
One of the greatest advantages Drosophila provides to Myc biology is 
the ease with which growth can be studied in a living animal. All dmyc 
mutations show profound growth defects. Null mutant embryos hatch into 
larvae at the same time as wildtype animals, but fail to grow and die early in 
the second larval instar (Pierce et al., 2004). 
Hypomorphic alleles are lethal at progressively later stages of 
development, depending upon their severity (Pierce et al., 2004; Maines et 
al., 2004). In animals bearing the weakest alleles, such as the original dm1 
mutation and dmycP0, development is delayed and yields small flies – the 
result of smaller cells – with short, thin bristles (Johnston et al., 1999). 
Animals carrying the slightly stronger dmycP1 allele also have a significant 
reduction in cell number. 
Interestingly, although the hypomorphic mutant flies are smaller than 
normal, they appear normally proportioned (Fig. 6) (Johnston et al., 1999; 
Moberg et al., 2004). Many of these same defects are characteristic of flies 
with growth deficits, and also appear in flies with mutations in genes 
encoding ribosomal proteins (the Minute class of mutations) and other 
components of ribosome biogenesis (Lambertsson, 1998).  
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Figure 6. dMyc controls animal growth. Flies expressing less dmyc, such as a viable 
dmyc hypomorph (dmycP0), are smaller in overall body size than wildtype flies (yw), and 
wing size is reduced approximately 15%. Conversely, flies with increased dmyc expression, 
from a Tubulin promoter-dmyc transgene (Tub>dmyc), are approximately 30% larger in 
overall body size than wildtype flies. [Modified from: de La Cova and Johnston, 2006] 
 
 
 
 
The existence of a broad dmyc allelic series with a range of 
phenotypes suggests that some developmental processes in the fly require 
dmyc more than others. dmyc is expressed in numerous tissues throughout 
fly development, and its expression occurs in a dynamic pattern (Gallant et 
al., 1996). It is expressed in both endoreplicating cells, which oscillate 
between G1 and S phase but do not divide, and in mitotic tissues (Pierce et 
al., 2004; Johnston et al., 1999). 
Use of the FLP/FRT technique of mitotic recombination to generate 
somatic dmyc mutant cells in an otherwise normal animal demonstrated that 
in all tissues examined, clones of dmyc mutant cells result in pronounced 
defects in cellular growth. This defect is manifested by a small cell size and 
by impaired progress through the cell cycle (Johnston et al., 1999). 
In endoreplicating larval cells that can normally achieve a DNA 
content upwards of 2000C, dmyc null cells fail to increase in size as 
development progresses, a defect that is directly related to the number of 
endocycles a cell undergoes (Pierce et al., 2004). Since the dramatic growth 
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of these cells is required to sustain the overall growth of a fly larva, the 
impaired growth of dmyc mutant endoreplicating tissue probably accounts 
for the growth arrest and subsequent death of these null mutant larvae 
(Pierce et al., 2004). dmyc is also required for growth of polyploid cells 
within the female germline, and in the diploid imaginal cells that give rise to 
the adult body structures of the fly (Maines et al., 2004; Johnston et al., 
1999). 
Proliferating dmyc mutant imaginal cells are markedly reduced in size 
and spend a disproportionate amount of the cell cycle in the G1 phase; 
these cells are also smaller in S, G2, and M phases (Johnston et al., 1999).  
Conversely, overexpression of dMyc in imaginal cells increases cell 
size by accelerating cellular growth, and when expressed throughout the 
animal the size of the fly is increased by nearly 30% (Fig. 6) (Johnston et al., 
1999; de la Cova et al., 2004). Collectively, these mutant phenotypes 
provide solid evidence that dMyc is required in vivo for cellular growth, and 
that it acts in a dose-sensitive manner. 
The vast majority of dmyc targets encode factors used in ribosome 
biogenesis (Orian et al., 2003, Hulf et al., 2005; Grewal et al., 2005). These 
targets include RNA Polymerase I and II transcribed genes, and many 
appear to be directly responsive to dMyc activity. dMyc overexpression is 
accompanied by a dramatic increase in nucleolar size and in pre-rRNA 
expression. Bigger nucleoli are usually a good indicator of increased 
ribosome activity (Grewal et al., 2005). This effect is not observed when 
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other growth regulating factors, such as the PI3K, Dp110, or Cyclin D/Cdk4 
are overexpressed (Grewal et al., 2005). 
Fibrillarin expression is also increased in these larger nucleoli, and 
the cytoplasm of larval salivary gland cells expressing dMyc are packed with 
ribosomes and polysomes, with a dense network of rough endoplasmic 
reticulum (Fig. 7). 
By contrast, in dmyc mutant larvae, pre-rRNA levels are low 
compared to controls. Levels of rDNA and nucleolar size are reduced 
(Grewal et al., 2005). As a whole, the data indicate that modulation of 
ribosome biogenesis is an important effector of dMyc during normal growth, 
with dMyc-dependent transcriptional regulation of ribosome biogenesis 
resulting in greater translational activity within the cell. 
 
 
Figure 7. dMyc regulates nucleolar size and ribosome biogenesis in vivo. Cells of the 
fly salivary gland overexpressing dMyc have increased ribosome content (dark dots in a 
and b), and larger nucleolar size (c and d) as visualized by Fibrillarin (red), and nuclear size 
(c and d) as seen by DAPI (blue). (Modified from: Grewal et al., 2005) 
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dMYC AND CELL CYCLE REGULATION 
 
 
Given its pivotal role in human cancer and in developmental control 
of growth, understanding how Myc regulates the cell cycle has historically 
been of great interest. Like vertebrate Myc, dMyc is required for efficient 
transit through G1 into S phase, as dmyc mutations stall cells in G1, and 
overexpression of dMyc accelerates G1 (Pierce et al., 2004; Maines et al., 
2004; Johnston et al., 1999). 
However, dMyc is not essential for cell cycle progression. This is 
clearly demonstrated in the female fly germline, where mitotically dividing 
cytoblast cell clones carrying a strong hypomorphic allele of dmyc still 
undergo all the normal divisions, producing the expected 16 cells of a 
normal germline cyst (Maines et al., 2004). On the other hand, as 
mentioned above, endoreplicating cells mutant for dmyc undergo 
significantly fewer rounds of S phase. The molecular nature of the defect in 
endoreplication is unclear, as dmyc cells still periodically express the G1 
regulators Cdk2, CyclinE and Dacapo, the fly p27cip/kip homolog, and are 
able to complete the entire endocycle (Maines et al., 2004).  
One possibility is that dMyc regulates the frequency of S phase entry 
in these cells. Consistent with this idea, overexpression of dMyc increases 
the rate of endoreplication in cells of the Drosophila fat body, and this effect 
is accompanied by (and dependent upon) oscillating activity of Cyclin 
E/Cdk2 (Pierce et al., 2004). 
Moreover, dMyc expression in endocycling cells can partially reverse 
a growth arrest imposed by expression of the phosphoinositol-3-kinase 
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(PI3K) adaptor p60, rescuing both endoreplication and cellular growth 
(Pierce et al., 2004; Maines et al., 2004). 
 
By controlling cellular growth and cell proliferation, dMyc has a major 
impact on the regulation of animal size. In contrast to the growth-regulating 
network of Insulin/PI3K and dTOR, dmyc expression is regulated by at least 
two of the major developmental signaling pathways that regulate pattern in 
Drosophila, Wingless (Wg)/Wnt, and Decapentaplegic (Dpp)/BMP/TGFβ. 
While Insulin/PI3K/dTOR signaling controls growth in response to nutrients, 
the responsiveness of dMyc to Wg and Dpp, which are also required for 
growth of many fly organs, suggests a model wherein developmental 
signals contribute to tissue growth, and ultimately body size and proportion, 
by regulating dMyc activity. 
 
 
 
dMYC AND CELL COMPETITION 
 
 
Recently, work in Drosophila has revealed a new aspect of dMyc 
function: high levels of dMyc provide cells with a competitive edge that 
allows them to kill nearby cells that have less dMyc. In the fly, cell 
competition is a process that is operationally defined by the progressive 
elimination of normally viable (but less “competitive”) cell types. 
When cell clones overexpressing dMyc are generated in the 
developing wing, such clones grow faster than the surrounding wildtype 
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cells, which in turn actually grow less than expected and die more frequently 
(de la Cova et al., 2004; Moreno et al., 2004). 
The ability of dMyc to induce cell competition is a remarkable 
property that is not shared by all growth regulators. Competition can be 
induced whenever neighboring cells differ in levels of dMyc. Wildtype cells, 
containing endogenous dmyc, are only killed when they reside near cells 
overexpressing dMyc.  
Likewise, although dmyc hypomorphic cells are viable when 
surrounded by each other, when they exist in somatic clones surrounded by 
wildtype cells, they are eliminated from the wing (Johnston et al., 1999). 
Similar competitive outcomes result from other manipulations that 
allow some cells to have higher dMyc levels than their neighbors. For 
example, loss of archipelago (ago), which encodes a Drosophila F box 
protein homologous to human Fbw7, results in elevated dMyc protein levels 
and a competitive advantage that allows ago mutant cells to overtake whole 
body structures while wildtype cells are eliminated (Moberg et al., 2004). 
Cells with mutations in receptors for patterning factors, such as Dpp, 
Wg, or EGF, or those deficient in ribosome biogenesis, such as Minutes, a 
large class of mutations in genes encoding ribosomal proteins, are also 
subject to competitive elimination (Burke et al., 1996; Johnston et al., 2003; 
Baker and Yu, 2001; Morata and Ripoll, 1975). 
Cells lost in competition die by apoptosis, but how the apoptotic 
program is initiated is not clear (de la Cova et al., 2004; Moreno et al., 2004; 
Moreno et al., 2002). 
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Two models have been proposed to explain how cell competition 
occurs (Fig. 8). In one model, less competitive cells are deprived of growth 
factors due to the capture of such factors by their more competitive 
neighbors (Milan et al., 2002). The elimination of cells unable to receive Dpp, 
Wg, or EGF is certainly consistent with this idea, as is a report that some 
Minute cells are deficient in responding to Dpp (Moreno et al., 2002). 
However, the predictions that this model makes do not always hold. For 
example, dMyc expression neither enhances a cell’s response to signals 
such as Dpp or Wg, nor alters the response of neighboring cells, as would 
be predicted from a ligand-capture model (de la Cova et al., 2004). 
A second model posits that competition is due to secretion of a factor 
that initiates an apoptotic program in neighboring cells. This model comes 
from the observation that although physical contact is not necessary for 
wildtype cells to be killed, they must be in close proximity to dMyc-
expressing cells (de la Cova et al., 2004). Thus, dMyc may allow cells to 
sense each other’s presence, and induce competition via a short-range 
signal.  
Interestingly, many of the Minute genes, as part of the large number 
of genes involved in ribosomal biogenesis, are dMyc transcriptional targets. 
Also, as mentioned above, dMyc expression is influenced by Wg and Dpp. 
These observations might imply that cell competition involving dMyc, a 
reduction in ribosome biogenesis, or lack of patterning factors, operate by 
the same mechanism. However, this has not been demonstrated, and the 
molecular mechanism of cell competition remains to be established. 
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Figure 8. Two models to explain dMyc induced cell competition. (1) cells expressing 
more dMyc deprive their neighbors of growth and/or survival factors and (2) dMyc 
expressing cells induce a short-range signal that kills nearby cells that express less dMyc 
[Modified from: de la Cova and Johnston 2006]. 
 
 
 
 
 
 
dMYC PROTEIN STABILITY AND DEGRADATION 
 
 
Given myc importance in the regulation of many different aspects of 
a cell’s life, like growth, proliferation and apoptosis, its expression is tightly 
regulated by multiple signaling events acting at transcriptional, translational 
and post-translational levels (Bernard and Eiles, 2006; Vervoorts et al., 
2006). Phosphorylation is one of the most relevant post-translational 
mechanisms by which Myc stability is regulated and has been described in 
depth for the mammalian c-Myc isoform (Fig. 9) 
c-Myc protein is rapidly stabilized in response to Growth Factors, 
since Ras-dependent MAPK activation is associated with c-Myc 
phosphorylation at Serine 62 in mammalian cell lines (Sears, 2004). At the 
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same time, this first event is ment to keep c-Myc presence in the cell under 
strict control because it triggers a second phosphorylation at Threonine 58, 
mediated  by the Glycogen-Synthase Kinase 3β (GSK3β) (Sears et al., 
2000) and subsequently the Serine 62 de-phosphorylation by the 
phosphatase PP2A. This mono-phosphorylated form of Myc is then 
recognized and bound by the ubiquitin-ligase Fbw7 that promotes its 
degradation by the proteasome pathway (Yeh et al., 2004). It must be 
noticed that GSK3β phosphorylation requires a priming event (Dajani et al., 
2001) which, for some proteins such as β-catenin/Armadillo or Cubitus 
interruptus (Ci), is carried out by members of the CKI family (Jia et al., 2002; 
Liu et al., 2002; Price et al., 2002; Yanagawa et al., 2002). 
Mutations of the Drosophila ubiquitin-ligase archipelago (ago),  
homologous to the mammalian Fbw7, result in dMyc protein accumulation 
suggesting that coordination between phosphorylation and ubiquitination is 
a conserved feature between species (Moberg et al., 2004). 
In addition to phosphorylation at its N-terminus, c-Myc protein 
stability is regulated by phosphorylation in the PEST domain (amino acids 
253-266), located near the conserved Acidic Box. Deletion of the Myc 
PEST domain enhances its protein stability (Gregory et al., 2000).  
Although the Drosophila Myc protein (dMyc) is only 26% identical to 
human c-Myc (the most represented form of the family) over its length, the 
homology increases up to 57% in critical functional regions such as the 
Acidic Box and the PEST domain (Gallant et al., 1996). Moreover, dMyc 
and c-Myc proteins share similar functions; human c-Myc can rescue lethal 
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dmyc mutations to viability (Benassayag et al., 2005) and dMyc is able to 
partially substitute for the proliferation defect of c-myc-deficient mouse 
embryo fibroblasts (Trumpp et al., 2001).  
Taken together all these data promped us to question if Growth 
Factors and Nutrients ability to control size could be mediated by Myc 
regulation either at its transciptional or at its protein level.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Regulation of Myc protein stability by phosphorylation. Schematic 
representation of Myc protein domains important for its stability (A). RAS/MAPK signaling 
activated by Growth Factors triggers Myc phosphorylation at Ser62 which results in its 
stabilization. At the same time the presence of this phosphate allows GSK3β binding and 
phosphorylation at Thr58. This second event targets Myc for degradation through the 
proteasome since PP2A is now able to remove the phosphate group on Ser62. Thr58 
mono-phosphorylated Myc protein bound to the ubiquitine ligase Ago is sent to proteasome 
for degradation. 
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Thesis outline 
 
Throughout development cellular and organ growth are regulated in a 
coordinated manner. Each cell and organ integrates hormonal signals, 
nutrients availability and intrinsic developmental programs to gain the 
correct final size. 
Description of pathways involved in these processes and the way 
they are integrated is important to understand how the growth control is 
achieved during development and provides new insights into mechanisms 
that cause aberrant growth in diseases as cancer. 
In recent years, biochemical analysis in cell culture and genetic 
dissection of growth control in model organisms allowed the identification of 
two evolutionarily conserved signaling pathways devoted to size 
determination: TOR signaling that responds to nutrients availability, and 
Insulin signaling involved in growth control in response to hormonal stimuli. 
Genetic studies suggest that a fine coordination between these two 
cascades exist that prevent a cell to divide prior it has reached a critical 
weight. 
Molecular mechanisms involved in this coordination are still poorly 
understood, nevertheless TOR and Insulin signalings are well conserved 
between Drosophila and vertebrates making the fruit fly an excellent model 
for studying the relative role of these two pathways in growth regulation. 
With regard to Myc protein, its involvement in size control has long 
been known. Mice and flies carrying a hypomorphic mutation of the myc 
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gene are smaller in size. Moreover, genomic and functional analysis 
suggests an involvement of a great percentage of genes transactivated by 
dMyc in metabolism regulation, ribosome biogenesis, protein synthesis and 
cell cycle progression. 
Growth Factors have been shown to rapidly stabilize Myc protein in 
mammalian cells, subsequent to activation of the Ras-ERK/MAPK cascade 
(Sears et al., 1999). At the same time our previous data clearly 
demonstrated dMyc protein up-regulation subsequent to Insulin and EGF 
subministration in Drosophila S2 cells. 
These results prompted us to further investigate, in an in vivo model,  
growth controlling mechanisms that show a dependence on Myc. Our 
analysis ranges from the characterization of dMyc protein stability to the 
dissection of InR/TORC1 pathway in order to understand Myc contribution 
to Growth Factors and Nutrients mediated growth. 
In fact, although a direct modulation of myc expression and/or protein 
stability from signaling controlling cellular and organismal growth could be 
predicted, until now it has never been observed in vivo due to the instability 
of Myc protein. To overcome this issue it is now available a new method of 
inducible gene expression that renders the UAS-Gal4 system conditional to 
the presence of a steroid in the culture medium (Rogulja and Irvine, 2005). 
This way it became possible to induce the transgene expression when the 
clone reached the appropriate size and, at that time, to check for the gene 
of interest. 
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In this work we were able to highlight the mechanism that leads to 
dMyc protein stabilization and to demonstrate a synergic behaviour of 
Insulin/TORC1 pathways on Myc proto-oncogene both in vitro and in vivo. 
Moreover we observed for the first time a genetic interaction between Myc 
and Rheb that seems to be TOR independent, opening new interesting 
perspectives toward the understanding of growth regulation. 
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Materials and Methods 
Cell culture and Western blot 
Drosophila Schneider S2 cells were grown at 25° C using Schneider 
medium (GIBCO) supplemented with 10% heat-inactivated FCS and 100 U.I. 
of penicillin/streptomycin (GIBCO). 
Treatment with Insulin and inhibitors: S2 cells were serum starved in 0.1 % 
serum for 12 hrs then various chemical inhibitors were added to the medium 
together with 1 um/ml of Insulin (from porcine Sigma) for 4 hrs at 25 °C. 
Cells were washed in PBS and lysed using a buffer containing 50 mM 
HEPES pH 7.4, 250 mM NaCl, 1mM EDTA, 1 % Triton and protease 
inhibitors. After measurement of the protein concentration, using the Biorad-
kit, proteins were separated by SDS-PAGE, electrotransferred to a 
nitrocellulose membrane, subjected to Western blot analysis with specific 
antibodies, and visualized by ECL-Plus (Amersham Pharmacia Biotech). 
Chemical Inhibitors were 10 µM for Wortmannin, 100 nM for Rapamycin 10 
µM for LiCl, 50 µM for MG132, 10 mM for Okadaic Acid, 10 µM for CHX 
(Sigma), 10 µM CKI-7 (US-Biological). 
Primary antibodies were:  anti-dMyc mAb (Prober et al., 2004 1:5); anti-actin 
mAb and anti vinculin mAb (1:3000 Sigma), anti HA (1:1000 Sigma). 
 
 - 42 - 
Quantitative real-time PCR 
Drosophila S2 cells were reared at the indicated condition (see Results) 
and total RNA was extracted using the RNeasy kit (Qiagen) and on-column 
DNase digestion to eliminate genomic DNA contamination. Reverse 
transcription was carried out with oligo-dT primers on 1 µg of RNA per 
sample using the Omniscript RT kit (Qiagen). For quantitative real-time 
PCR we used SYBR green PCR mastermix (Applied Biosystems) on a ABI 
7900HT machine, and the following primer pairs: 
rp49 (ref): 5’- AAACGCGGTTCTGCATGAG -3’ (reverse), 
5’- GACGCTTCAAGGGACAGTATCTG -3’ (forward); 
dmyc:       5’- CATAACGTCGACTTGCGTG-3’ (reverse),  
5’- GAAGCTCCCTGCTGATTTGC -3’ (forward); 
fibrillarin (ref): 5’- ATGCGGTACTTGTGTGGATG -3’(reverse), 
 
All PCR reactions were carried out in triplicate, and control PCR-reactions 
on “no RT” templates (i.e. templates which had been mock reverse-
transcribed) confirmed that genomic DNA had been efficiently removed. 
 
Microarray analysis 
S2 cells were seeded in 6 wells plates, washed, and 15 µg of dsRNA 
against dmyc or lacZ in 3 biologically independent replicates were added in 
each well in serum free medium. After for 12 hrs cells were treated with  
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Insulin for 4 hrs, then washed and lysated as described (Hulf et al., MCB 
2005). Total RNA was harvested from the different samples and processed 
for analysis on Affymetrix whole-genome microarrays v 2.0 
 
Fly lines 
 
Fly stocks were obtained from the Bloomington stock center, with the 
exception of: 
• yw; UAS-Dp110 
• yw; UAS-PTEN 
• UAS-Rheb 
• tor2l1/TM3 
• w; FRT82>Rheb7A1/TM6b  
kindly provided from H. Stocker ETH-Zurich; 
• yw, dmycPL35, tub>FRT>(dmyc-cDNA)>FRT>GAL4, ey-Flp / Y 
• w, dmP0  tub-FRT>(dmyc-cDNA)>FRT GAL4 ey-Flp / Y 
• yw, dm+ tub-FRT>(dmyc-cDNA)>FRT GAL4 ey-Flp / Y 
characterized in Bellosta et al., PNAS 2005 
• hs-Flp; tub-Gal4, UAS-GFP; FRT82>tub-Gal80 [Hs-CD2] 
were a gift from M. Zecca, Columbia Medical Center, NYC; 
• UAS-dco3 
• FRT82B dco3/TM6B 
stocks were a gift from M. Noll; 
• sggD127 hsFLP;  FRT82B  Dp(1;3)w+67K, sgg+  / FRT 82B Hs-GFP 
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from our collaborator J. Jiang, UT Southwestern Med Center, Dallas, TX, 
USA 
 
Clone Generation and Transgene Induction 
 
For generation of Flp-out clones, flies of the genotypes 
• w, hs-Flp;UAS-dp110 
• yw, hs-Flp;UAS-PTEN, 
• yw, hs-Flp; UAS-Rheb/CyO, 
• yw, hs-Flp; UAS-Tor 
• yw, hs-Flp; UAS-TorTED 
were crossed to UAS-GFP; Act-Gal4:PR/TM6b flies (Rogulja and Irvine, 
2005). Flp-out clones were then generated by heat shock for 30 min at 37°C. 
Heat shocks were performed 48h AEL. 
Gal4:PR was activated by transferring larvae to instant food (Instant 
Drosophila Medium, Connecticut Valley Biological) containing RU486 
(Mifepristone, Sigma). Two grams of instant food was mixed with 7 ml of 
water previously supplemented with RU486, resulting in a final 
concentration of 20 µg/ml of Mifepristone. 
 
For generation of MARCM clones, flies of the genotype: 
• w; UAS-dMyc; FRT82>Rheb7E1/TM6b 
• w; FRT82>Rheb7E1/TM6b 
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were crossed to a hs-Flp; tub-Gal4, UAS-GFP; FRT82>tub-Gal80 [Hs-CD2]. 
Mitotic clones were then generated by heat shock for 1 hr at 37 °C, 48 and 
72hrs AEL and detected with an α-CD2 staining (M. Zecca) and GFP 
visualization. 
 
Analysis of cell size and number in the adult eyes 
Flies were reared at 25 °C under reproducible growth conditions and were 
age matched (3 days old males) before determin the ommatidial size and 
number.  Ommatidia were counted from scanning electron micrographs 
(SEM) pictures. From the same photographs, the size of the ommatidia was 
calculated by measuring the area of 20 ommatidia located in the center of 
the eye using Adobe Photoshop as previously reported (Bellosta et al, 
PNAS 2005). 
 
 
Immunofluorescence analysis 
 
Third instar larvae were dissected in PBS 1X. Imaginal wing or eye discs 
collected were fixed in 4% paraformaldehyde/PBS for 20 min at room 
temperature, washed twice in PBS 1X then permeabilized by repeated 
washes in 0.3% Triton X-100/PBS prior to incubation with specific 
antibodies. 
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All antibodies incubations were performed in 3% BSA/PBT. Primary 
antibodies used were mouse anti-dMyc (Probe and Edgar 1:5); mouse anti-
CD2 (a gift from M. Zecca 1:1000) rat anti-caspase-3 (DHSB 1:200); rat 
anti-ELAV (DHSB 1:1000). Secondary antibodies were anti-mouse Alexa 
Fluor 555 (Invitrogen 1:200); anti-rat FITC (Invitrogen 1:200). After washing, 
discs were mounted in Mowiol and analyzed in a confocal microscope. 
Images were processed using LSM Image browser (from Zeiss) and Adobe 
PhotoShop software at 20X and 40X magnification. 
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GENETICS 
 
 
UAS-Gal4 system (Brand and Perrimon, 1993) 
 
The UAS-Gal4 is a binary system that allows, in the fly, to study the 
effects of the ectopic expression of a gene of interest. 
Gal4 is a powerful transcriptional activator of Saccharomyces 
cerevisiae, that recognizes and binds to specific regulatory sequences 
called UAS (Upstream Activating Sequences). 
In Drosophila it is possible to construct two separate transgenic lines. 
A first line contains the Gal4 sequence under the control of a regulatory 
element of a Drosophila’s gene, that can induce the expression in specific 
moments of development and in specific body districts. The second line 
contains a construct in which the cDNA sequence of the transgene of 
interest is put downstream one or more UAS elements. 
 - 48 - 
By crossing those 2 lines it is possible to originate a progeny 
containing both constructs, and this allows the expression of the Gal4 
transactivator, that in turn activates the gene put under the UAS control in a 
pattern-specific manner (Brand and Perrimon, 1993). 
A large series of promoters exists stored in stock centers (the most 
important is the Bloomington Stock Center) that can drive Gal4 expression 
in defined types of cells or tissues; it is also possible to drive Gal4 
expression by a heat shock promoter, that permits a temporal control of 
induction. 
The use of UAS-hairpin constructs further allows to silence post-
transcriptionally the expression of certain genes (UAS-RNAi). 
 
 
FLP-FRT (Xu and Rubin, 1993) 
 
In Drosophila the yeast binary sistem FRT-Flp that allows site-specific 
recombination is broadly used. 
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The Flippase (Flp) recombinase induces recombination at the level of 
specific sequences called FRT (Flippase Recognition Targets) (Golic and 
Linquist, 1989). 
This system can be used to generate genetic mosaics to study LOF 
mutations. 
Stocks are available with the FRT sequence in the pericentromeric 
region of all the chromosome arms, this allows the exchange of the entire 
chromosome arm by mitotic recombination. 
Mitotic recombination by Flp activation can be induced in 
heterozygous mutants for a gene of interest; as a result it is possible to 
obtain a clone homozygous for the mutation and a wild type twin clone (Xu 
and Rubin, 1993). 
The possibility to generate homozygous mutant clones is very useful 
in the study of lethal recessive conditions and to investigate cell-cell specific 
interactions. Most commonly, Flp is expressed under the control of a heat-
shock promoter (hsFLP) as it ensures the possibility to control either the 
developmental stage in which to induce recombination or the clone number 
that is related to heat pulse length; the distribution of clones is instead 
random within the animal. 
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Flp - Out (Neufeld, 1998) 
 
 
 
The FLP-Out technique permits the overexpression of a UAS 
controlled sequences in a clone of cells. A FLP-Out construct consists of a 
constitutive promoter (i.e. actin or tubulin) followed by an FRT sequence, a 
marker with a polyA terminator, a second FRT sequence and a Gal4 
sequence. 
The Flippase expression can induce the excision of the DNA 
fragment between two FRT sites, and the constitutive promoter can thus 
transcribe the Gal4 sequences. This, in turn, permits the expression of all 
the UAS-transgenes present in the line. Most of the time, a FLPout line also 
carries a cell marker (GFP or LacZ) under the UAS control. 
In this essay (see results) we made wide use of this technique. In 
particular we worked with a FLP-Out line, in which the Gal4 transcriptional 
activity is rendered conditional to the presence of an hormone (Mifepristone) 
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in the medium. This allowed us to limit the UAS-transgene expression to a 
shorter window of time late in development in order to analize its effect on 
dMyc protein right away (Rogulja and Irvine, 2005) 
 
 
 
 
 
 
MARCM system (Lee and Luo, 1999) 
 
The MARCM system (Mosaic Analysis with a Repressible Cell Marker) (Lee 
and Luo, 1999) allows to generate homozygous mutant cells uniquely in 
mosaic tissues.  
To achieve this goal, the yeast GAL80 protein was introduced into the 
GAL4-UAS binary expression system in Drosophila (Brand and Perrimon, 
1993). The MARCM system initially contains cells that are heterozygous for 
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a transgene encoding the GAL80 protein, which inhibits the activity of the 
GAL4 transcription factor. 
Following FLP/FRT-mediated mitotic recombination, the GAL80 
transgene is removed from one of of the two daughter cells, thus allowing 
expression of a GAL4-driven reporter gene specifically in this daughter cell 
and its progeny (see figure). If a mutation is present on the chromosome 
arm in trans respect to the GAL80 transgene, the uniquely labeled GAL80-
negative (GAL80-/-), Gal4 expressing cells should be at the same time 
homozygous for this mutation. Therefore, using the MARCM system, it is 
possible to specifically label clones of cells homozygous for any mutation in 
a mosaic tissue. 
In particular the MARCM system has shown to be useful in the study 
of genetic interactions because of its ability to generate LOF clones for 
recessive mutations in which it is possible to overexpress any other gene 
under the control of a UAS element. 
 
 
 - 53 - 
 
 
 
 
 
RESULTS 
 
Chapter 1: 
dMyc phosphorylation regulates its stability 
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CKIα and GSK3β induce dMyc ubiquitination and degradation through 
the proteasome pathway 
 
 Our characterization of dMyc role in growth regulation downstream of 
Growth Factors/Nutrients availability began with the analysis of its protein 
stability since in mammals Growth Factors stabilized c-Myc protein through 
MAPK-mediated phosphorylation at Serine 62 (Sears, 2004). At the same 
time this mono-phosphorylated c-Myc form is recognized as a target by 
Glycogen-Synthase Kinase 3β (GSK3β) that add a phosphate group on c-
Myc Threonine 58 (Sears et al., 2002). 
 At the same time, GSK3β in some cases requires a priming event of 
phosphorylation in order to recognize and bind its substrates (Dajani et al., 
2001). The priming phosphorylation in these case is carried out by  
members of the Casein Kinase I (CKI) family (Jia et al., 2002; Liu et al., 
2002; Price et al., 2002; Yanagawa et al., 2002). 
 Given these preliminary evidences, in order to determine how a cell 
regulates dMyc activity in response to growth promoting cues, we first 
decided to investigate if the mechanisms that target Myc proteins for 
degradation are conserved between species and more interestingly if CKI 
kinases are required in Drosophila as priming kinases for GSK3β taking 
part to its protein regulation. 
 We first assessed if dMyc amino acid sequence could contains 
specific domains potential targets for both kinases (CKI = S/T-XX-S/T; 
GSK3β = S/T-XXX-S/T as described in Obenauer et al., 2003) and indeed 
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we found several of them (Figure 1A and Table 1). 
 Once identified these domains are putative targets for 
phosphorylation, we next analyzed the effect of S2 cells transfection with 
HA-tagged constructs for CK1α and GSK3β or their Kinase Dead  inactive 
(KD) variants on dMyc protein stability. As shown in Fig. 1B dMyc protein 
was considerably reduced in presence of both kinases (Fig. 1B), while the 
expression of their KD mutants caused the opposite effect.  
 Cycloheximide (CHX), a protein synthesis inhibitor, was used to 
further confirm these first results. S2 cells were treated with CHX and dMyc 
protein turnover over time in presence of GSK3β or CKIα or their KD was 
analyzed at different time points. The intensity of each band obtained in 
western blot and corresponding to different treatments was quantified and 
reported in graph (Figure 1C). CKIα or GSK3β activity decreased 
endogenous dMyc half-life from 35 minutes to approximately 15 minutes. 
Conversely, expression of their kinase-dead forms increased dMyc half-life 
up to 80 and 75 minutes, respectively.  
 We further confirmed this regulation to occur on dMyc protein by 
analyzing dmyc-mRNA and, as expected, we were not able to detect any 
significant change either in presence of the kinases or of their inactive 
forms (Figure 2). 
 Moreover, since it was demonstrated that phosphorylation of c-Myc 
by GSK3β allows Myc ubiquitination by the ligase Fbw7, we tested whether 
the presence of GSK3β or CKIα kinase would affect dMyc protein 
ubiquitination. We used a stable S2 cell line trasfected with HA-dMyc, 
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expressed under a hsp70 promoter (Bellosta et al., 2005) and, at the same 
time, we blocked the proteasome activity with MG132 to avoid rapid dMyc 
degradation. S2-HA-dMyc cells were transfected with different kinases or 
their inactive mutants whose expression was induced with CuSO4. 
Subsequently, a one-hour heat shock was applied to induce hs>HA-dMyc 
expression. Cells were lysed, dMyc was immunoprecipitated with anti-dMyc 
monoclonal antibodies and ubiquitination levels were analyzed by western 
blot. 
 As depicted in Fig. 1D, CKIα or GSK3β expression promotes dMyc 
ubiquitination, while expression of the kinase-dead mutants do not interfere 
with this process. 
 Taken together our data indicate that CKI family members represent 
yet uncharacterized  components of Myc degradation pathways, which, 
similarly to GSK3β, regulate Myc protein stability through the ubiquitination 
and proteasome degradation. 
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Figure 1.1: CKIα and GSK3β kinases induce ubiquitin-dependent degradation 
of dMyc. 
Schematic representation of dMyc protein. The amino acid sequences of dMyc 
phosphorylation mutants and homologous c-Myc sequences are shown. Amino 
acids changed by site-directed mutagenesis have been underlined (A). 
CKIα and GSK3β regulate endogenous dMyc protein stability. S2 cells were 
transfected with the indicated HA-tagged kinases mutants and protein expression 
was induced using copper sulfate. Their level of expression was quantified by 
immunoblotting using anti-HA. Endogenous dMyc protein was quantified using anti-
dMyc antiserum. Actin was used as loading control. Molecular markers are shown 
to the right (B). 
dMyc Half-life measurement in presence of CKIα and GSK3β or their KD mutants. 
The graph represents the quantification of endogenous dMyc levels after CHX 
supplementation. Cells were lysed at the indicated time points after CHX treatment 
and dMyc expression was visualized by western blot using anti-dMyc antibodies. 
Intensity of dMyc bands was quantified in pixels from the scanned X-Ray film using 
AdobePhotoshop.  Background was calculated from an equivalent area in each 
lane and subtracted from the value for dMyc in the respective lane. Time 0 was set 
at 100. Data are plotted as percentages over control for each point. These 
experiments were repeated three times (C). 
GSK3β and CKIα kinases mediates dMyc ubiquitination. The stable S2-HA-dMyc 
cell line  was transfected with various kinases and their expression was induced 
using copper ions (Bellosta et al., 1995). Upper panel: HA-dMyc was 
immunoprecipitated from cell extracts using anti-HA antiserum and its ubiquitinated 
forms were visualized using anti-ubiquitin antiserum. Lower panel: HA-dMyc and 
HA-kinases epression was visualized using anti-HA antiserum. MG132 was added 
to the medium at heat-shock to avoid Myc degradation. 
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Table 1.1. (a) Percentage of identity between Drosophila melanogaster (D.m.) and 
human aminoacidic Myc protein sequences, calculated using DNA-Strider TM 1.3. Amino 
acids substitutions in D. m. Myc protein are represented in bold. Underlined are the 
conserved substituted amino acids in the human Myc sequence.  The residues in dMyc-
PII and PV, putative substrates for GSK3β are represented in shadow and for CKIα in 
engrave . 
(b) The stability of dMyc mutants was compared to that of dMyc-WT, which, in our 
biochemical experiments, was estimated to be of 30 minutes. 
 
 
 
 
Figure 2.1. Relative dmyc-mRNAs level after over-expression of CKIα, CKIε, 
GSK3β kinases or their kinase-dead (KD) mutants analyzed by qRT-PCRs in S2 
cells.  
The kinases, or kinase-dead mutants, do not affect endogenous dmyc-RNAs level. 
S2 cells were transfected with the indicated kinases and their expression was induced by 
CuSO4 supplemented medium for 12 hrs. Cells were harvested and lysed for protein or 
RNAs extraction. Kinases presence in the lysates was quantified by western blot using 
anti-HA antiserum (A). Relative dmyc-mRNAs level was measured by qRT-PCR, 
ribosomal protein 49 (rp49) was used as control (B).  
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In vivo reduction of GSK3β, CKIα or CKIε results in dMyc protein 
accumulation 
 
 
Figure 3.1: dMyc is up-regulated in sgg/Gskβ mutant cells. 
(A-A”) Immunostaining of third instar wing imaginal disc for 
endogenous dMyc (green) or for the protein Ci155 (red), which 
is expressed in the anterior compartment of the disc and is up-
regulated in sgg mutant cells. Endogenous dMyc levels are 
reduced along the zone of non-proliferative cells (ZNC) of the 
Dorsal/Ventral region and in the hinge, but are higher in the 
wing pouch and notum. (B-C”) expression of dMyc increases in 
clones with reduced level of sgg, marked by the expression of 
Ci155 in the anterior as well as in the posterior compartment of 
the discs where Ci155 is not expressed (asterisk). Discs are 
oriented A/P with Anterior to the left and D/V with Ventral to 
the top. 
 
 
 The  Drosophila homologue of mammalian GSK3β is known as  
shaggy (sgg) or zeste-white3 (zw3) (herein referred to as sgg). It acts as a 
negative regulator of the Wnt/Wingless (Wg) signaling and is involved in a 
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range of developmental processes, from pattern formation to cell fate 
determination and proliferation (Cohen and Frame, 2001). We examined in 
vivo the effect of reducing sgg expression on dMyc protein level in third 
instar wing imaginal discs.  At this stage of development, dMyc is primarily 
expressed in the notum and wing pouch (Figure 3A-A” arrowhead) except 
for a stripe of cells along the dorsal-ventral boundary known as Zone of 
Non-proliferative Cells (ZNC). Here dmyc is transcriptionally repressed by 
Wg signaling (Duman-Scheel et al., 2004; Herranz et al., 2008). sgg mutant 
clones were induced by mitotic recombination and marked by Ci155 
staining. Ci155 is normally expressed in the anterior compartment of the 
wing imaginal disc in absence of sgg. 
 dMyc accumulation was visible in sgg mutant clones falling in the 
peripheral region of the wing disc and in the hinge (Figure 3B-C” arrows), 
while clones in the wing pouch failed to show dMyc accumulation 
(arrowhead). 
 To explain this positional effect we considered that Wg signaling is 
known to downregulate dmyc-mRNA in the ZNC (a defined stripe of cells at 
the dorsal-ventral boundary) while its effect slopes down while moving away 
from this boundary (Johnston et al., 2003; Strigini et al., 2000). At the same 
time sgg silences Wg signaling during development. For this reason sgg 
mutant clones are supposed to activate Wg signaling and, as a 
consequence, downregulate dmyc at its mRNA level (Duman-Scheel et al., 
2004; Herranz et al., 2008). These experiments indirectly excluded a role 
for Hh signaling in the regulation of dMyc in the wing disc since dMyc 
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protein also accumulated in clones located in the posterior compartment, 
where Ci normally is not expressed (Figure 3C asterisk). 
 A more straightforward way to show the same results is depicted in 
Fig 4 where sgg mutant clones were induced randomly in the wing disc and 
directly detected by GFP coexpression. dMyc protein was analized by 
immunohistochemistry. Clones falling outside of the wing pouch were 
considered. They show overgrowth features and dMyc staining 
enhancement suggesting an important role for Myc in control of shape and 
size. 
 
 
 
Figure 4.1. sgg mutant clones show dMyc upregulation. 
 
 We next analyzed how CKIs regulate dMyc expression in vivo. CKIs 
are believed to modulate the Wingless signaling cascade (Knippschild et al., 
2005)  however their effect has been subject of controversy. In this work we 
considered two different CK1 isoforms: CK1α was shown to act as a 
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negative regulator of Wg signaling because it induces the degradation of its 
main transducer (β-catenin/armadillo). The interesting feature of this 
degradation mechanism consists in the requirement of CKIα as a primer 
kinase for a subsequent phosphorylation event carried out by GSK3β (Amit 
et al., 2002).  In contrast, CKIε was identified as a positive regulator of Wg in 
mammals and Xenopus because it stabilizes the β-catenin (Peters et al., 
1999). 
 In Drosophila, Zhang and co-workers demonstrated that 
hypomorphic CKIα mutations co-operate with CKIε-RNAi to induce ectopic 
Wg signaling during limb formation, suggesting a synergistic effect for these 
kinases (Zhang et al., 2006). Using genetic recombination and dsRNAi 
techniques, we knocked down CKIα or CKIε kinases in vivo and we 
analyzed whether this would affect dMyc protein. 
 Mutant clones for dco3 allele (Zilian et al., 1999), the Drosophila 
homologue of mammalian CKIε, were induced by mitotic recombination and 
marked by the absence of GFP (Fig. 5). At high magnification it was 
possible to appreciate dMyc protein accumulation in homozygous dco3 
mutant clones falling in the hinge domain (Figure 5A).  
 Using a combination of Flp-out, UAS/Gal4 and RNAi techniques, we 
next assessed the CKIα contribution to dMyc stability in CKIα-RNAi clones 
of cells of the wing imaginal disc. Silencing CKIα by the use of a RNAi 
construct, results in different outcomes according to the position of the 
clone inside the wing disc. CKIα-RNAi clones in the hinge, visualized by 
GFP coexpression, showed dMyc protein accumulation (Figure 5B , arrow), 
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while silencing CKIα in the ZNC region cells resulted in dMyc protein down-
regulation (arrowhead). Because CKIα, together with GSK3β, is known to 
downregulate Wg signaling in vivo (Liu et al., 2002), which in turn down 
regulates dmyc at its transcriptional level (Duman-Scheel et al., 2004;  
Herranz et al., 2008), the reduced dMyc expression in the ZNC region might 
be the result of Wg activation as already noticed for sgg clones. 
 Taken together, our data suggest that both CKIε and CKIα are able 
to down-regulate dMyc protein in vivo, however this effect is dependent on 
patterning cues like Wg signaling that seem to be epistatic on the kinases 
control of dMyc stability. 
 
 
Figure 5.1: dMyc is up-regulated in cells with reduced levels of dco3/CkIε 
and CKIα dMyc protein expression (red) in dco3/CKIε mitotic clones. Clones 
were induced at 65±2 hours after egg laying (AEL) by mitotic recombination. 
dMyc protein level was analyzed in dco3/CkIε mutant clones (unstained) and 
compared to sibling clones (marked with GFP). Higher magnification of the 
area (right) shows an increase in dMyc protein level in clones dco3 (marked 
with a white line) (A). Flip-out clone expressing UAS-CKIα-RNAi in the wing 
imaginal discs induced at 52 ±2 hours AEL. Endogenous dMyc expression in 
UAS-CK1α-RNAi clones (marked by GFP) is visualized by immunostaining with 
anti-dMyc antiserum (red). Expression of dMyc is higher in clones located in 
the hinge region (arrow) and lower in the ZNC (arrowhead) (B). 
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In vitro characterization of dMyc phosphorylation mutants reveals that 
dMyc-PII and Acidic Box mutants are resistant to CKIα and GSK3β 
degradation 
 
 Analysis of the dMyc amino acid sequence reveals the presence of 
conserved motifs that are potential substrates for phosphorylation by CKIs 
and GSK3β (Figure 1A). In order to understand the contribution of these 
domains to dMyc protein stability, we performed site-directed mutagenesis 
and substituted Serine and Threonine residues within the dMyc-PI, PII, and 
PV boxes into Alanine. We also converted the Acidic Box (AB) Glutamic 
Acid and Aspartate Residues into glycine and asparagine, respectively 
(Table 1.1). All dMyc mutants were tagged with the hemagglutinin (HA)-
epitope at their N-terminus and expressed in S2 cells using the UAS/Gal4 
system. 
 We then analyzed if the newly identified dMyc domains would render 
dMyc protein sensitive to CKIα and GSK3β kinases-induced degradation. 
 dMyc-WT, dMyc-PI, dMyc-PII, dMyc-PV and dMyc-AB were co-
expressed in S2 cells together with increasing concentrations of CKIα or 
GSK3β kinases. The kinases expression was induced with cupper sulfate 
and dMyc protein level was analyzed by western blotting using anti-HA 
antiserum. 
 As shown in Figure 6, dMyc-PII and dMyc-AB were resistant to 
degradation induced by the two kinases, while dMyc-PI and dMyc-PV 
presented degradation kinetics similar to dMyc-WT. 
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These data suggest that dMyc-PII and the Acidic Box contain functional 
domains necessary for the regulation of dMyc protein stability, and this 
effect is regulated by CKIα and GSK3β kinases.  
 
 
Figure 6.1: In vitro stability of dMyc-WT and mutants in presence of GSK3β and 
CKIα kinases. HA-dMyc-WT and dMyc phosphorylation mutants were transfected in S2 
cells together with the indicated concentrations (µg) of plasmids encoding HA-CKIα or 
HA-GSK3β kinases. Proteins expression was analyzed in the cell extracts by western 
blot using anti HA antiserum. 
 
 
 
 
Increased dMyc stability inhibits ommatidial differentiation and 
induces cell death during eye development 
 
 Once performed a detailed in vitro analysis on dMyc protein stability 
we next switched to an in vivo approach in order to characterize the 
physiological relevance of our dMyc phosporylation mutants. 
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We took advantage of FLP-out technique and of the UAS-Gal4 
system to screen for enhancers or attenuators of the dmycP0 phenotype.  
dmP0 hypomorphic mutation results from a P-element insertion in the 
dmyc promoter. dmycP0 flies are less viable and fertile than wt (Johnston et 
al., 1999). To overcome this problem we made use of a mosaic dmycP0 line 
(dmycP0 tub>FRT>[dmyc-cDNA]>FRT>GAL4 ey-FLP, hereafter called 
ey>dmycP0) designed to rescue dmycP0 level of myc to wt through an 
exogenous dmyc-cDNA. The same line is also carrying a Flp (Flippase) 
enzyme, expressed under the ey (eyeless) promoter, which is thought to 
cut dmyc-cDNA off in eyes and cephalic capsula and bring these tissues 
back to the dmycP0 genetic background (Bellosta et al., 2005). Moreover 
the recombination event allows the expression of a GAL4, specifically in the 
ey territories and as a consequence, to overexpress any transgene, under a 
UAS-promoter, in a dmycP0 mutant background. 
 Since dMyc expression modulates growth and ommatidial number of 
during compound eye development (Johnston et al., 1999), we performed 
genetic epistasis experiments to assess the contribution of our various 
dMyc phosphorylation mutants. 
 dMyc-PI expression increased ommatidial size, but to a lower extent 
than dMyc-WT (317 µm2 in ey>dmycP0/Y; dMyc-PI/+ and 341 µm2 in 
ey>dmycP0/Y; dMyc-WT/+). In addition, the total ommatidial number in 
ey>dmycP0/Y; dMyc-PI/+ flies (756) was higher than that of ey>dmycP0/Y; 
dMyc-WT/+ animals (633), prompting us to investigate whether dMyc-PI 
could be less effective than dMyc-WT in inducing  apoptosis (Montero et al., 
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2008).  
 The α-caspase3 staining confirmed our hypothesis and enforces our 
previous biochemical observations on dMyc-PI phosphorylation mutant 
stability underlining the deleterious effect these mutations have in vivo. (Fig. 
6).  
 The same kind of analysis was conducted for dMyc-PII, dMyc-PV 
and dMyc-AB, showing their ability to increase ommatidial size of 
ey>dmycP0/Y eyes (Fig. 7B), but at the same time resulting in a dramatical 
decrease of ommatidial number and a strong reduction of the head capsule 
tissue (Figure 7A). We ascribed these defects to Myc-dependent induction 
of apoptosis (Moreno et al., 2008) and we monitored caspase-3 staining to 
confirm our assumption. 
 As shown in Figure 8, ectopic expression of dMyc mutant forms 
correlates with intense caspase-3 but at the same time with loss of ELAV 
neuronal marker, suggesting that, beside an intensification of cell death, the 
strongest phosphorylation mutant forms render cells unable to undergo 
differentiation. According to its lower stability, compared to dMyc-WT, 
dMyc-PI affected neither photoreceptor differentiation nor apoptosis, further 
suggesting a significative correlation between stability and the correct 
development of proliferating tissues.   
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Figure 7.1: Expression of dMyc mutants in vivo affects ommatidial size and 
number. 
Representative scanning electron micrographs (SEM) of adult eyes from 
ey>dmycP0/Y flies expressing UAS-dMyc-WT, UAS-dMyc-PI, UAS-dMyc-PII, UAS-
dMyc-PV, and UAS-dMyc-AB transgenes (A). Graphics show the quantification of 
ommatidia size and number of the indicated genotypes. Standard deviations were 
calculated based on the number of animals analyzed and is indicated in parentheses 
(B).  
 
 
 
 
Figure 8.1  (next page): Expression of dMyc-PV and dMyc-AB inhibits 
ommatidia differentiation and increases apoptosis in eye imaginal discs. 
Photographs of eye imaginal discs from third instar larvae of the indicated genotypes 
were stained for dMyc (red) and ELAV (green) expression (A-F) or for apoptosis 
using anti-active-caspase 3 antibodies (blue) (A”-F”). Photographs were taken at 20x 
magnification. The morphogenetic furrow is indicated by arrowhead. 
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Figure 8.1. see previous page for legend 
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Chapter 2: 
 
dMyc protein expression is sensitive to Insulin 
and TOR activity 
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In vitro and in vivo treatments with Insulin increase dMyc protein level 
 
Using biochemical and in vivo approaches we previously 
demonstrated that dGSK3β/sgg and members of the CKI family of protein 
kinases negatively affect dMyc protein stability (Galletti et al., 2009). By 
phosphorylating dMyc on specific residues these two kinases are able to 
target dMyc protein for degradation through the proteasomal pathway. 
Moreover we showed to which extent dMyc protein stability correlates with 
cell growth and how detrimental dMyc overexpression can be in an in vivo 
model. 
Since GSK3β lays downstream of pathways activated by growth 
factors availability (Sears et al., 2002) and CKIs are known to prime many of 
GSK3β targets for phosphorylation (Jia et al., 2002; Liu et al., 2002; Price et 
al., 2002; Yanagawa et al., 2002), our first observations are particularly 
interesting because they suggest that growth promoting signalings might 
impinge on dMyc to adjust cell size and that they would do that regulating its 
persistence into the cell. 
Drosophila Insulin/Insulin-like Growth factors system (IIS) is highly 
homologous to that found in mammals and is able to fulfill the homeostatic 
function of vertebrate Insulins (Broughton et al., 2005; Rulifson et al., 2002; 
Shingleton et al., 2005), mediating glucose import and nutrient storage. At 
the same time it is able to control cell growth during development, 
performing the developmental function of the mammalian Insulin-like growth 
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factors (IGFs) (Esfradiatis A., 1998; Baserga R., in Cell growth Cold Spring 
Harbor press, 2004). 
Downstream of Insulin Receptor (InR) activation, the PKB/Akt kinase 
is able to phosphorylate and inactivate GSK3β/sgg (Zhang et al., 2006). 
This notion, together with the observation that dMyc and Insulin both 
act as growth inducers in a cell autonomous fashion (Edgar B., in Cell 
Growth, Cold Spring Harbor press, 2004), prompted us to further investigate 
the effect of Insulin signaling activation on dMyc protein. 
We performed a microarray analysis on Drosophila S2 cells, an 
embryo-derived cell line, trasfected either with a dMyc-RNAi or a LacZ-RNAi 
constructs, the latter as control (Table 1.2). We first verified whether we 
could obtain a stable dMyc downregulation with our dMyc-RNAi construct (4 
folds dmyc-mRNA downregulation respect to Lac-Z-RNAi trasfected cells; 
Table 1.2), then we treated dMyc-RNA-interfered and Lac-Z-RNA-interfered 
cells with Insulin and we scored for genes, induced by Insulin but no longer 
upregulated in the absence of dMyc.  
Most of the genes insensitive to Insulin treatment in dMyc-RNAi 
transfected cells encode ribosomal proteins or factors involved in RNA 
processing/binding, suggesting that Insulin stimulated cells augment their 
mass,  through a Myc-dependent intensification of their biosynthetic 
activities (Table 1.2).  
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Table1.2: dMyc targets in S2 cells. After dMyc-RNAi or Lac-Z-RNAi 
transfection cells have been treated with Insulin. The list of genes whose 
expression resulted up- or down-regulated is reported. E-box: presence of the E-
box relative to the transcription start site between +1 and +500.  * Ratio: 
determined by a comparison of dmyc RNAi microarrays with the corresponding 
Lac-Z RNAi control. All down-regulated genes listed were found in two replicates 
with a significative ratio [higher then 1.5 fold (p-value 0.01)]. Negative and 
positive numbers indicate folds of down- or up- regulation relative to control. 
diminutive (dmyc) resulted down-regulated 4.57 times, indicating the good 
efficiency of the dmyc-RNAi treatment. 
 
 
In vitro and in vivo assays we performed in S2 cells clearly evidenced 
dMyc protein upregulation after Insulin stimulation. Figures 1A and B 
summarize the first result obtained in tissue culture, showing an 
intensification of dMyc staining after 4 hours incubation with Insulin. This 
effect is further enhanced in presence of a proteasome inhibitor (MG132). 
These results derived from cell culture were confirmed in vivo by the 
analysis of protein extracts from yw larvae provided with 1µg/ml of Insulin 
supplemented food compared with control larvae fed on a regular medium. 
As shown in Fig. 1C, Insulin fed yw larvae show dMyc protein upregulation, 
detected by western blot on total larval lysates.  
To further evaluate the mechanism that leads to dMyc protein 
accumulation we made use of specific chemical inhibitors known to interfere 
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with the Insulin pathway in Drosophila S2 cells. We then analyzed dMyc by 
western blot.  As shown in Fig. 1D, dMyc protein upregulation after Insulin 
stimulation depends on PI3K activity, since the presence of its inhibitor 
(Wortmannin) is able to revert the Insulin effect. More interestigly treatment 
with LiCl, a specific inhibitor of GSK3β, results  in an additional increase of 
dMyc protein compared to Insulin treatment alone (Fig. 1D), indicating that 
even in presence of growth factors, GSK3β inhibition is required for dMyc to 
accumulate. 
We next asked if the increase in dMyc protein detection observed in 
all treatments could be associated with a corresponding increment of its 
mRNA. Total mRNA was extracted from Insulin treated S2 cells and 
endogenous dmyc-mRNA was isolated by RT-PCR with appropriate primers 
(see Materials and Methods). Cells were kept in 0.1% Serum prior to 
stimulation. Rp48-mRNA was used as internal control while Fibrillarin, being 
a nucleolar protein, target of dmyc (Grewal et al., 2004), was adopted as a 
dMyc activity marker. As the graph in Fig. 2 demonstrates, Insulin treatment 
in S2 cells increased endogenous dmyc-mRNA, compared with 0,1% serum 
treatment, without affecting rp48-mRNA. At the same time Fibrillarin-mRNA 
raised more than 1,5 times respect to control, indicating a significative 
enhancement of nucleolar activity in Insulin stimulated cells that correlates 
with dMyc protein and mRNA increments. 
Taken together these data suggest that growth factors impinge on 
dMyc with two mechanisms, first through post-translational modification “via” 
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dGSK3/sgg phosphorylation (Galletti et al., 2009), secondly at its post-
transcriptional level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.2. Insulin stimulation induces 
dMyc protein accumulation both in vitro 
and in vivo. dMyc protein accumulates in S2 
cells after 4 hrs Insulin exposure. MG132 was 
used to inhibit the proteasome and further 
enhance Insulin effect on dMyc protein 
accumulation (A-B). Larval extract from yw 
larvae fed with 1µg/ml Insulin. dMyc 
accumulates in vivo in presence of Insulin (C). 
PI3K inhibition (Wortmannin) attenuates dMyc 
accumulation after Insulin treatment, whereas 
silencing GSK3β/sgg activity (LiCl) enhances 
dMyc  increase (D).  
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Schematic representation of InR/Nutrients signaling converging on dMyc 
 
 
 
 
TORC1 modulates dMYC post-transcriptionally  
 
Insulin pathway activation is known to regulate translation through 
TOR-mediated phosphorylation of S6K and 4EBP (Hay and Sonenberg, 
2004; Manning and Cantley, 2003). 
TOR is an aminoacid responsive kinase that can be found in two 
complexes named TORC1 and TORC2 (Inoki et al., 2005). TORC1 is the 
only complex responsive to Rapamycin inhibition also known to 
phosphorylate S6K and 4EBP. TORC1 activation depends upon the small 
GTPase Rheb (Ras Homolog enriched in Brain) which in turn for its growth 
promoting activity requires the TSC1/TSC2 complexes to be inactive 
(reviewed by Neufeld, 2003) 
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Since we found dMyc protein and mRNA both to be responsive to 
Insulin stimulation, we next tried to verify to what extent TOR-dependent 
mRNAs translation could contribute to dmyc-mRNA and protein 
accumulation. 
We tested whether Rapamycin inhibition of TOR would affect Insulin-
dependent dmyc-mRNA upregulation. We double treated S2 cells with 
Insulin and Rapamycin and analyzed dMyc protein by western blot and 
mRNA by RT-PCR.  
Arresting TORC1 activity prevents Insulin-dependent dMyc 
accumulation both at the mRNA (Fig. 2A) and protein level (Fig. 2B). 
However Rapamycin seemed to be able to negatively act only on the newly 
synthesized mRNA with no alteration of the endogenous dmyc-mRNA level. 
This suggests that TORC1 somehow regulates the “de novo” synthesis of 
dmyc-mRNA but it does not change its “steady state”. 
While endogenous dmyc-mRNA doesn’t vary much in presence or 
absence of Rapamycin, dMyc protein seems to decrease below the 
endogenous amount (confront Fig. 2 A-B). These data are in agreement 
with recent observations from Teleman and co-workers (Teleman et al., 
2008), which demonstrate that TOR has only a modest impact on dMyc 
transcription regulation, while it seems to regulate dMyc mostly post-
transcriptionally with a mechanism not yet identified. 
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Figure 2.2. dmyc-mRNA and protein 
responsiveness to Insulin and 
Nutrients signaling. Insulin treatment 
increases dmyc-mRNA in S2 cells (A). 
TORC1 inhibition (Rapamycin) is able to 
revert the Insulin-dependent dMyc 
accumulation both at the mRNA (A) and 
protein level (B). Endogenous dMyc 
protein is negatively affected by 
Rapamycin treatment alone (B). 
 
 
 
 
dRheb expression increases dMyc protein level through GSK3β 
inactivation 
 
As already metioned in the Introduction of this dissertation the Ras-
like gene Rheb was shown to be required for growth throughout metazoa 
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(Yamagata et al., 1994; Reuther and Der, 2000; Urano et al., 2000; Urano et 
al., 2001; Im et al., 2002; Panepinto et al., 2002). 
This effect of Rheb-dependent growth enhancement is thought to rely 
on TOR activity (Patel et al., 2003; Stocker et al., 2003). Moreover TOR 
signaling is known to negatively regulate GSK3β/sgg through direct 
phosphorylation by S6K in mammals (Zhang et al., 2006). According to our 
previous data showing a dependence of dMyc protein stablity on GSK3β 
activity (Galletti et al., 2009), GSK3 inhibition by S6K phosphorylation 
should result in dMyc protein accumulation.  
In order to validate this model, we first assessed dMyc 
responsiveness to aminoacids availability. We provided S2 cells with an 
aminoacids rich culture medium and we monitored dMyc protein by western 
blot after increasing periods of exposure (Fig. 3A). Already after 30 minutes 
of exposure we were able to observe dMyc protein induction above its 
endogenous level. This correspondence between aminoacids presence and 
dMyc accumulation persisted and reached its plateau after 120 minutes. On 
the other hand the levels of actin protein as loading control didn’t change in 
our assay, proving the specificity of dMyc response to Nutrient and suggest 
that, given a nutrients rich environment, cells engage in biosynthetic 
activities upregulating growth promoting factors. 
We next verified wheter GSK3β/sgg phosphorylation status would be 
affected by TORC1 activation and at the same time we monitored dMyc 
protein expression, by western blot. A stable tub-Gal4 cell line, constitutively 
expressing the Gal4 trancriptional activator, was co-transfected either with 
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UAS-Rheb and UAS-Myc or with UAS-S6K and UAS-Myc constructs.  All 
the UAS constructs were HA tagged, they were detected with a α-HA 
antibody and recognized according to their molecular weight. The 
requirement of a double transfection came from technical difficulties to 
detect subtle changes in the endogenous dMyc protein in these kind of 
experiments. GSK3β/sgg phosphorylation at Ser9 (as a marker of its 
inactivation) was clearly visible after Rheb overexpression, whereas S6K by 
itself failed to strongly reproduce this effect, although a moderate dMyc 
induction was detectable. We argue the S6K defeat might be due to the fact 
that it needs to be activated in order to manifest its activity . At the same 
time, our data clearly demonstrate a requirement for TOR signaling on dMyc 
protein stability through S6K-dependent GSK3β/sgg inactivation, 
demostrating a functional conservation of this pathway between Drosophila 
and mammals (Zhang et al., 2006). 
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Figure 3.2. TORC1 contributes to dMyc protein stabilization. S2 cells were 
provided with aminoacids and dMyc protein was detected at the indicated time point. 
Longer aminoacid exposure correlates with a proportional intensification of dMyc signal 
(A). This effect might be the result of the TORC1-dependent GSK3β/sgg inhibition 
through its phosphorylation at Ser9 (B). 
 
 
 
 
PTEN, TOR and Rheb show significative epistatic interactions with 
dmyc 
 
Given the biochemical results so far presented and the similarity of 
phenotypes between dmyc hypomorphic flies and mutans of Insulin and 
TOR cascades (Johnston et al., 1999; Montagne et al., 1999; Zhang et al., 
2006; Stocker et al., 2003), we next wished to assess the possibility that 
dMyc could act in vivo downstream of one or both of these growth 
controlling pathways. To this purpose a detailed epistasis analysis was 
performed using the adult eyes.  
A 
B 
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We took advantage of the same system described in Chapter 1 of 
the Results section (Bellosta et al., 2005) to screen for enhancers or 
attenuators of the dmycP0 phenotype.  
Using the ey>dmycP0 line and ey>dm+ as a control (see Materials 
and Methods), we analyzed whether ectopic expression of Dp110 and 
PTEN, respectively positive and negative regulators of Insulin signaling 
would significantly modulate the dmyc contribution to the adult eye 
development. 
 
          
Figure 4.2. Epistatic interaction of InR and TORC1 signaling with dmyc. SEM 
analysis of ey>dm+ and ey>dmycP0 eyes overexpressing different modulators of InR or 
TORC1 pathways. 
 
 
 
TABLE 2.2.  cell size and cell number of ey>dm+ and ey>dmycP0 eyes 
overexpressing various transgenes. 
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As shown in Fig. 4 and reported in Table 2, ectopic Dp110 
expression totally rescued the morphological defect of dmycP0 eyes 
resulting in 31% increase of ommatidial size. These effect is slightly more 
pronounced (40%) in the ey>dm+ background. Ommatidial number of 
dp110 overexpressing eyes was greatly increased in both genetic 
backgrounds, in line with dp110 role in proliferation control. In contrast, 
overexpression of PTEN showed an 8% reduction of the ommaditial size of 
ey>dm+/Y flies, which is dramatically increased to 43% in the ey>dmycP0/Y 
background.  In addition to its effect on cell size, PTEN overexpression 
reduces the ommatidial number of ey>dm+/Y from 710 to 538 (Table 2.2). 
This reduction is further enhanced in ey>dmycP0/Y males where 98% of 
flies show very small and slightly misshaped eyes (Fig. 4), suggesting that 
inhibition of Insulin signaling by PTEN dominantly affect the role of dMyc in 
growth and proliferation during eye development. 
With a similar approach we subsequently analyzed the contribution 
of TORC1 to myc-dependent growth during eye development. Since a 
controversial effect of TOR kinase overexpression on growth has been 
reported  both in eye and wing discs (Hennig and Neufeld, 2002) and will 
be further discussed in our clonal analysis, we decided to avoid TOR direct 
overexpression and make use of dRheb and dS6K, both normally activated 
by aminoacid availability and to make use of a null mutant form for TOR 
(tor2l1). 
Ectopic expression of dRheb increased the ommatidial size by 22% 
in the ey>dm+ background (from 237 ± 10 to 289 ± 16) and of about 16% 
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(from 217 ± 9 to 253 ± 6) in the dmycP0 eyes (Fig 4 and Table 1). More 
compelling results were obtained with UAS-dRhebAV4 overexpression.  
dRhebAV4 derives from a P-element insertion within the 5’ UTR of dRheb 
and it has been shown to act as a null allele in absence of a Gal4 
transcriptional activator (Patel et al., 2003). 
dRhebAV4 overexpression results in ommatidial size increase of 88% 
in ey>dm+ eyes, while the size increment was only about a 54% in dmycP0 
background, indicating a significative contribution of dmyc in the growth 
phenotype induced by dRheb. The strong size increment of ey>dm+ 
ommatidia seems to be counteracted by a decrease of their number. This 
mechanism of compensation has been extensively described in the 
Introduction section of this thesis and appears to be conserved even when 
dRhebAV4 is overexpressed in a dmycP0 background. ey>dmycP0/Y; UAS-
RhebAV4 eyes are still bigger than dm+ and dmycP0 one, but their ommatidia 
never reach the size of ey>dm+/Y;UAS-RhebAV4 counterparts. At the same 
time their number is remarkably decreased even if to a lower extent than in 
ey>dm+/Y;UAS-RhebAV4 eyes. 
Moreover we were able to demonstrate that RhebAV4 overexpression 
triggers apoptosis in ey>dm+ eyes (Fig. 5), which no longer takes place in 
ey>dmycP0; UAS-RhebAV4, probably accounting for the more pronounced 
reduction in cell number of the former. This effect of dRheb on apoptosis 
during development has never been observed before and more 
interestingly it shows to be dmyc dependent. 
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With regards to the investigation about a direct TOR contribution to 
the dmyc-mediated effect on growth we used the tor2l1 null allele (Oldham 
et al., 2000) in our epistasis screening. As shown in Fig. 5, heterozigosity 
for tor2l1, did not result in ommatidial size reduction in the ey>dm+/Y 
animals. However a 14% reduction in ommatidial size was observed when 
tor2l1 was in trans-heterozygosis with dmycP0 allele. Moreover no changes 
in the ommatidial number were found between the ey>dm+; tor2l1/+  and  
ey>dmycP0; tor2l1/+   lines, (Fig 4 and Table 2.2) confirming that TOR plays 
a major role in cell growth rather than in cell division.  
Similarly, ectopic expression of dS6K or its activated form showed 
only a 19% increase of ommatidial size in the ey>dm+ eyes and 11% in the 
ey>dmycP0 eyes indicating a minor requirement for S6K during eye 
development. 
 
  
  
Figure 5.2. RhebAV4 
overexpressing eyes 
buffer cell size 
variation with cell 
number modulation. 
The endogenous level of 
apoptosis occurring 
during eye discs 
development is shown in 
the upper panel both for 
ey>dmycP0 and ey>dm+  
3rd instar discs with an α-
caspase3 staining. 
RhebAV4 overexpression 
enhances apoptosis 
(lower panel). The cell 
death intensification 
appears to be dmyc-
dependent because it is 
attenuated in a dMycP0 
background (left). 
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Genetic interaction of dmyc with members of the InR-TORC1 signaling 
in wing imaginal discs 
Our attempts to analyze in vivo, at the cellular level the effect on 
dMyc protein regulation by Insulin and TOR signaling, have been initially 
inconclusive for technical reasons. As most of cell cycle regulators, dMyc 
protein has a short half-life (about 30’ in S2 cells) that needs to be tightly 
regulated, as its misexpression is detrimental for the cell. 
Therefore cells have evolved mechanisms to buffer changes in dmyc 
expression rapidly modulating its protein stability, in order to mantain its 
physiological steady state (Galletti et al., 2009). 
For this reason the use of conventional techniques for clonal analysis, 
requesting at least 48 hrs between clones induction and protein detection, 
might not be useful to detect subtle changes in protein expression, 
especially when such a protein will be degraded shortly after its synthesis.  
Moreover, ectopic expression of genes that would reduce dmyc level 
will result in cell competition between the two populations of cells with 
different myc levels, (de la Cova et al., 2004; Moreno et al., 2004) finally 
leading to the elimination of lower-expressing-myc cells and negatively 
affecting the analysis. 
For these reasons we took advantage of a new method for 
conditional gene expression in genetic mosaics that represents a 
modification of the standard UAS-Gal4/Flp-out technique.  
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This new developed system renders the expression of the UAS-
transgene conditional to the presence of a hormone (RU486, Mifepristone) 
in the medium, allowing the experimenter to obtain a temporal control on 
transgene expression (Rogulja and Irvine, 2005). 
Using this technique we were still able to induce the clone formation 
48hrs AEL, this set of cells expressing the Gal4 as a fusion protein with the 
hormone receptor (PR) that prevents its binding to UAS-sequences on DNA 
(see Materials and Methods).  
We then let clones grow for additional 72hrs, then we provided 
larvae with RU486 to set the Gal4 free from the PR inhibition and allow the 
binding to its target genes. 
After 5 hours exposition to the hormone, we analyzed dMyc protein 
by immunohistochemistry (Fig 6). 
Clones expressing Dp110, the catalytic subunit of PI3K, clearly 
showed dMyc protein accumulation while inhibition of Insulin pathway, by 
the use of PTEN phosphatase overexpression, resulted in dMyc protein 
downregulation. Interestingly, dMyc autonomous modulation inside the 
clone also triggers a strong non-autonomous effect in the nearby cells 
which respond adjusting their endogenous Myc level in the opposite way 
(arrow) (Gallant, 2005).  
Our observations provide for the first time evidence that cells can 
adjust their endogenous dMyc levels in response to Insulin stimulation 
indicating that Myc acts downstream of this signaling. 
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Having demostrated a genetic interaction between Insulin signaling 
and dmyc, we next turned to confirm our results involving TORC1, derived 
from the epistatic analysis in the adult eye. 
With the same approach described for Dp110 and PTEN we 
generated random flp-out clones overexpressig either a wt form of the TOR 
kinase or a modified form known as TORTED (toxic effector domain) whose 
kinase domain has been mutated in order to be inactive (Hennig and 
Neufeld, 2002). A controversial effect of TOR overexpression on growth in 
Figure 6.2. PTEN and dp110 
overexpression results in dMyc protein 
modulation. Clones of cells, generated with 
a flp-out event are marked with the use of a 
GFP. Overexpression of a positive regulator 
of InR signaling (Dp110) in these cells 
associates with an increased dMyc staining 
(A-A’ arrow). On the other hand PTEN 
overexpression turns off the Insulin signal 
and downregulates dMyc protein (B-B’). A 
non autonomous effect on dMyc protein is 
visible in cell nearby the PTEN 
overexpressing clone (B – arrowhead) 
 
Overexpression of a dominant 
negative form of the TOR kinase 
(TORTED in  C-C’) results, as 
exprected, in dMyc attenuation. 
Surprisingly TORwt overexpression 
produced the same outcome (D-D’).  
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Drosophila was already reported. In fact, while the TOR family of protein 
kinases are known to be conserved regulators of eukaryotic cell growth, 
proliferation and metabolism (Schmelzle and Hall, 2000; Raught et al., 2001) 
it is unclear whether incremental increases in TOR activity or expression 
can potentiate cell growth rates, or whether TOR activation sends a 
permissive signal necessary but not sufficient for growth. 
Surprisingly, dTOR overexpression caused phenotypes remarkably 
similar to those of dTOR loss of function mutations, including reductions in 
cell size and proliferation rate, accumulation of cells in the G1 phase of the 
cell cycle, and specific genetic interactions (Hennig et al., 2002). 
Having implemented the RU486 method of conditional gene 
expression in our lab, we decided to verify whether a transient TOR or 
TORTED overexpression could unmask their effect on growth. Surprisingly 
both transgenes, when ectopically driven in clones of cells, resulted in dMyc 
downregulation (Fig. 6 C-C’ and D-D’) suggesting again a dualty in TOR 
behaviour. 
In light of the potential scaffolding function of TOR proteins, we 
suggest that abnormally high TOR expression may reduce signaling output 
by titrating and diluting essential cofactors, thereby inhibiting formation of 
functional signaling complexes. Furthermore data so far presented 
underlined a significative dependence on Myc for dRheb mediated growth, 
opening the possibility that Rheb could regulate cell size in a TOR-S6K 
indipendent fashion.  
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TORC1 AND dMYC REGULATION 
 
Teleman and coworkers in a recent publication demonstrated the in 
vivo requirement for Myc in TORC1-mediated growth control, since knock-
down of TSC1 failed to induce tissue overgrowth in the absence of dMyc 
(Teleman et al., 2008). Nevertheless, dMyc overexpression did not show to 
be able to rescue the impaired growth caused by low TOR activity in TOR∆P 
mutant clones (Teleman et al., 2008). The authors argued that although 
Myc is essential in the growth-promoting signaling network downstream of 
TORC1, myc expression is not sufficient to fulfill the requirement for TOR 
activity. 
Considering these results, the well known controversy about the 
ambiguous effect exerted on growth by TOR overexpression (Hennig and 
Neufeld 2002), our epistatic analysis in the adult eye and our clonal data, 
we decided to obtain a more straightforward result by overexpressing UAS-
dmyc transgene in clones of cell homozigous for Rheb mutation, using the 
MARCM technique. 
Rheb7A1 is a strong hypomorphic allele (Stocker et al., 2003), 
homozigous lethal whose growth features can only be charachterized in a 
clonal assay. 
Clones of cells Rheb7A1/Rheb7A1, or bearing even stronger null 
dRheb mutations, are prone to disappear from the epithelial layer, 
outcompeted from their wild type neighbours and have the tendency to form 
elongated, thin clones that often fuse together maybe in the attempt to 
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minimize the contact with the surrounding more competitive cells (Stocker 
et al., 2003).  
We generated Rheb7A1/Rheb7A1 mutant clones, marked with a UAS-
GFP, by mitotic recombination and we compared their growth rate with their 
siblings generated in the same recombination event and supposed to grow 
at the same extent (Fig. 7). 
Although these data are still very preliminar and lack of a substantial 
statistical analysis, the genetic mutant background of Rheb7A1/Rheb7A1 
mutant clones, negatively affected their growth rate respect to the sibling 
clone. When mutant clones were induced 48hrs AEL a very little amount of 
them survived to the L3 stage (72 hrs later), when they are detected by 
immunofluorescence. Mutant clones induced 72 hrs AEL have more 
chances to survive but they still grow poorly respect to siblings (Fig. 7 A-B). 
dMyc overexpression in the Rheb7A1/Rheb7A1 background partially 
rescued the growth defect of mutant clones. They still never reach the 
sibling dimensions, being in the average 1/4 of their size, but they show to 
be able to survive competition from wt cells when induced 48 hrs AEL (Fig 
7 A’-B’). Moreover Rheb7A1/Rheb7A1;UAS-dmyc clones, induced 72 hrs AEL 
show a small but significative increase in size respect to Rheb7A1/Rheb7A1 
clones induced at the same time indicating a genetic interaction between 
Rheb and Myc in growth regulation that we suppose to be TOR 
independent. 
 
 
 - 92 - 
 
 
   
     
Figure 7.2. dMyc overexpression rescues Rheb mutant growth 
defect. Rheb7A1 homozygous mutant clones suffer of growth 
disadvantage. Clones induced 48hrs AEL are rarely detectable and 
significativey smaller than wt siblings (A). dMyc overexpression in 
Rheb7A1 mutant background is able to rescue their growth 
disadvantage allowing them to survive throughout development (A’ 
see Table 2).  An even more pronounced effect is visible in clones 
induced 72hrs AEL. UAS-dMyc; Rheb7A1 expressing clones (B’) 
appear to be slightly bigger than Rheb7A1 clones (B) although they 
never reach the siblings size. 
Picture were taken at two different magnifications (A-A’: 20X; B-B’ 
40X) 
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Discussion 
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A large body of literature documents in both mice and Drosophila the 
involvement of Insulin pathway in growth regulation, probably due to its role 
in glucose and lipids import, nutrient storage, and translation of RNAs 
associated with ribosome biogenesis. 
Studies in cell culture have implicated the Myc family of transcription 
factors as regulators of the cell cycle that are rapidly induced in response to 
growth factors. 
Myc is a potent proto-oncogene that is rearranged and 
overexpressed in a wide variety of human tumors. Evidences from in vivo 
studies on Drosophila and mammals suggest a critical function of myc in 
regulating cell growth (Iritani and Eisenman 1999; Johnston et al. 1999; Kim 
et al. 2000; de Alboran et al. 2001; Douglas et al. 2001). This role is also 
supported by our analysis of Myc targets in Drosophila, which include 
genes involved in RNA binding, processing, ribosome biogenesis and 
nucleolar function (Orian et al 2003, Bellosta et al, 2005, Hulf et al, 2005).  
The fact that Insulin signaling and Myc both seem to be involved in 
cell growth regulation suggests that they may interact with each other. 
However, genetic evidences indicating that Insulin signaling regulates Myc 
in vivo were lacking.  
Here we show for the first time a direct modulation of dMyc in 
response to Insulin stimulation/silencing both in vitro and in vivo. In 
presence of growth factors a cell needs to engage in macromolecular 
biosynthesis and, in the case of Myc, Insulin stimulation intensifies its 
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expression and protein stability, resulting in enhanced ribosomal biogenesis 
and protein translation.  
dp110 overexpression in clones of cells of the wing disc leads to 
dMyc protein accumulation (Fig. 6.2 A-A’) . As shown by Zhang and 
coworkers (Zhang et al., 2006) PI3K elicits GSK3β inactivation in mammals. 
For this reason our analysis on dmyc contribution to InR/TOR signaling 
mediated growth begins with the characterization of dMyc protein stability.  
Our biochemical data demonstrated that CKIα and GSK3β induce 
dMyc ubiquitination and degradation through the proteasome pathway, 
while dMyc protein results more stable in presence of their KD mutants (Fig. 
1.1). Neither the wt form of the two kinases nor their KDs were able to alter 
dmyc-mRNA, confirming they act at post-transcriptional level (Figure 2.1). 
In vivo down-regulation of GSK3β and CKIα or CKIε kinases in wing 
imaginal discs resulted in dMyc protein accumulation, particularly in the 
hinge and notum regions. This effect is masked in cells adjacent to the ZNC 
(Figure 3.1-4.1-5.1). Reduction of GSK3β and CKIα activates Wingless (Wg) 
signaling (Liu et al., 2002), which in turns is known to negatively regulate 
dmyc-RNA specifically in the ZNC (Duman-Scheel et al., 2004;  Herranz et 
al., 2008; Johnston et al., 1999). This functional relationship might explain 
the failure to detect dMyc protein in clones crossing ZNC. Moreover, this 
positional effect suggests that dMyc activity is regulated by patterning 
signals active during development.  
 Our analysis of dMyc amino acid sequence uncovered novel 
conserved domains, which serve as potential phosphorylation substrates 
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for CKIs or GSK3β. Aminoacid substitution inside these domains rendered 
dMyc insensitive to phosphorylation and increases its protein stability. The 
in vivo effects associated with this prolonged perduration of dMyc protein 
inside the cell are in some cases detrimental, as shown in overexpression 
experiments in the eye imaginal disc. Ectopic expression of the stable 
mutants dMyc-PII, dMyc-PV and dMyc-AB results in a visible eye defect 
(Figure 7.1), accompanied by a reduction of the head capsule and a 
decrease of ommatidial number. This is particularly visible in dMyc-PV and 
AB overexpressing eyes. 
 A closer analysis on third instar larvae eye imaginal discs revealed 
that expression of these mutants induced apoptosis during disc 
development. Cell death is not only limited within the dMyc expressing 
territories (cell autonomous) but also detectable in the neighboring cells 
(non-cell autonomous; Figure 8). This phenomenon illustrates the role of 
dMyc in cell competition, a well-documented mechanism of size regulation 
in which high expressing dMyc cells kill slower proliferating neighbours (de 
la Cova et al., 2004). 
These first results demonstrate the physiological importance of dMyc 
protein titration during development and allowed us to speculate that 
pathways such as Ras or Insulin signaling responding to Growth Factors, 
may control growth and survival through the activity of different kinases that 
in turn, phosphorylating Myc on different residues, determine its half life. 
Being Myc a transcription factor involved in cellular mass regulation, 
proliferation and cell death its phophorylation status could directly correlate 
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with the decision wheter or not to engage in biosinthetic activity or rather 
stop proliferating and die. 
In support to this hypothesis, we produced data underlining that 
activation of the DILPs (Drosophila Insulin-like peptides) pathway increases 
dMyc protein stability both in vitro and in vivo (Fig. 1.2) 
Moreover our work showed that dMyc up-regulation in response to 
DILPs signaling requires activation of the TOR pathway. Our in vitro assays 
demonstrate that dMyc protein accumulates in response to amino acid 
stimulation and that TOR inhibits GSK3β activity, since Rheb 
overexpression in S2 cells promotes its phosphorylation at Ser9 (Fig.3.2). 
At the same time, while InR pathway is able to increase dmyc-mRNA 
in cells, TORC1 signaling mostly appears to impinge on myc post-
trascriptionally. In fact, the use of Rapamycin as a TORC1 inhibitor do not 
seem to affect dmyc-mRNA in S2 cells but visibly lowers dMyc protein 
under its endogenous level (Fig. 2.2). 
Furthermore our data prove that Rheb but not S6K, both downstream 
of the TOR signaling cascade, contributes to the dMyc induced growth 
phenothype in the eye, suggesting that Rheb might control growth 
independently of TOR/S6K (Fig . 4.2) 
To better understand the complex interplay between Myc and the 
Nutrients cascade and given the controversial effect of TOR overexpression 
on growth (Hennig and Neufeld, 2002) we decided to further investigate the 
cell response to Rheb modulation. 
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RhebAV4 overexpression under the eyless promoter resulted in a 
dramatic overgrowth of the eye that is attenuated in a dmyc hypomorphic 
background. Moreover the ommatidial size increase is balanced in RhebAV4 
overexpressing eyes with a reduction of their number that is achived 
through apoptosis. Cell death is strongly abated in absence of myc 
suggesting that Rheb is able to regulate organ size during development 
inducing cell death in a dmyc dependent fashion. Moreover these results 
infer that in order to reach its correct proportions during development, every 
organ needs to finely tune cell growth and apoptosis. Both these processes 
show a dependence on dmyc since dmyc overexpressing eyes 
significatively overgrow. Moreover we characterized the behaviour of highly 
stable dMyc protein isoforms, in vivo in the eye imaginal discs and once 
again we were able to demonstrate how dmyc overexpression can be 
detrimental leading to massive apoptosis and impaired development 
(Galletti et al., 2009). 
In a recent paper Teleman and coworkers addressed the issue of 
dMyc dependent growth control downstream of TORC1 signaling (Teleman 
et al, 2008). Although they provided evidence of an interplay between TOR 
and dMyc in size regulation they couldn’t  rescue the growth defect of Tor 
mutants clones with dmyc overexpression coming to the conclusion that the 
contribution of TOR on cell growth is only partially dependent on Myc. Our 
results with RhebAV4 overexpression and Rheb7A1 mutant rescue might 
provide a different explanation. In our MARCM analysis we were able to 
rescue the Rheb7A1 growth disadvantage by overexpressing Myc. Clones of 
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cells mutant for Rheb are small in size and are prone to be eliminated by 
the neighbor more competitive cells. Rheb7A1/Rheb7A1 mutant clones 
induced early during development are very rarely detectable at the end of 
larval development while dmyc expression in this genetic background is 
able to rescue their viability. Moreover Rheb7A1;UAS-dMyc clones induced 
later in development appear bigger in size respect to Rheb7A1/Rheb7A1 
clones induced at the same time but lacking dMyc expression. These 
results suggest the possibility that dMyc lays downstream of Rheb in the 
growth promoting pathways activated by Aminoacids.  
Taken together our data raise the intriguing possibility of the 
existence of a yet uncharacterized branch of the Nutrients pathway that 
impinge on Myc to promote growth, downstream of Rheb activation but in a 
TOR-independent fashion. 
 
The present work addresses for the first time the role of dmyc in 
cellular and organismal growth downstream of Growth factors and Nutrients 
availability. These signaling pathways are often deregulated in many 
diseases like diabetes or cancer. Moreover myc mutation impairs 
development while its misexpression has been found associated to the vast 
majority of cancer forms. 
For these reasons, we believe the dissection of the signaling used by 
cells to grow or restrain growth as well as the characterization of the 
mechanisms that control cell, organ and body size during development, 
beside their speculative interest, have a great applicative potential. 
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